Medical Device ASIA, November-December 2015 issue

Vol.7 No.6 | November-December 2015 | New Delhi

PHARMACEUTICAL

Portable

Revolutionary

Sugar disease

Packaging

Air Purifiers

In India

AnaesthesiaNew!

Machine

Veterinaryhematology

analyzer

New Launch!

RelaunchedMerck Brand

DeficientVitaminIndians

MEDICAL FAIR ASIA ‘sMEDICINE + SPORTS

CONFERENCE in 2016

AWARENESSPROTEIN

CAMPAIGN

e d i t o r i a l

Medical Device ASIA | November-December 2015 | 3

h i g h l i g h t s

Vol.7 No.6 | November-December 2015 |Annual Suscription: Rs.2,000 | Overseas: US$250

The Indian medical device industry has a potential to grow from current $4.4

billion to $7 billion by 2016, a premier US-India business body has said as it called for a dialogue with the government to address issues of ease of doing business.

The medical device industry, having enjoyed fast growth and healthy profits for many years, faces much tougher times ahead. The industry is operating in a drastically changed environment with reduced government funding exacerbating the difficulties.

Europe’s medical device industry: leadership challenges in a changing world, reveals that more innovative talent strategies are required to deliver solutions that not only improve patients’ health but also reduce overall healthcare costs. A proactive talent strategy is essential: in many cases, companies need to look outside their own industry to enhance their leadership bench-strength and to remain competitive while coping with high-levels of change.

India is a land full of opportunities for players in the medical devices industry. The Indian hospital services generated revenue of more than US$ 45 Billion in 2012. This revenue is expected to rise at a CAGR of 20%

Indian medical device industry Growth to 2016during 2012-2017 generating immense possibilities for players in the market. Besides, Indian medical service consumers have become more conscious towards their healthcare upkeep. Thanks to India’s economic growth and a rise in penetration of medical insurance, the 300 Million plus middle class population of India can now afford almost any of its healthcare needs. Such a scenario presents immense opportunities for players in the medical devices business.

Currently, import constitutes almost 70% of the Indian medical devices market. A historical trend analysis of the total import value of medical devices in India shows that despite a depreciating currency, the trend to import has remained positive. For RNCOS’ study, the company analysts have conducted a thorough trend analysis of medical device imports in the country. What medical devices are majorly imported; what are the key drivers behind their import; and what are the challenges that imports of these medical devices face; such and other factors depicting the overall scenario of medical device imports in the country are provided in the report. Similar facts have been reported for exported and locally manufactured medical devices, providing a complete picture of the Indian medical devices industry. Research findings from the study will help players in identifying distinct opportunities. They will get an insight on which medical devices are exported to which countries. Also, local players will get to know which medical devices are majorly imported and thus can be intelligently targeted.

4 MEDICAL FAIR ASIA to host inaugural Asian edition of MEDICINE + SPORTS CONFERENCE in 2016

6 International Medical Devices and Supplies Fair Ends 10 MEDICA and COMPAMED - Show Report 13 Air Liquide Medical Systems 20 SharpísRevolutionaryAirPurifiersHelpsPrevent

Airborne Diseases 22 New Rigel 288 safety analyser is a big Plus for faster

medical device testing 24 Sugar disease growing at alarming rate in India 26 POULTRY INDIAíS PROTEIN AWARENESS CAMPAIGN 32 Merck Brand Relaunched 33 7outofevery10IndiansareVitamindeficient:

Metropolis Study 35 MEDICAL FAIR ASIA 2016 37 MediAngelsbagsHealthcareExcellenceAward 40 Diatron to launch new 5-part veterinary hematology

analyzer at Medica 45 Aarogyam Energy Jewellery 50 Kamani Oils receives FDA License 52 IntroducingaSaferHandSanitizerwithLasting

Protection!

In just about nine months,Singapore will once again playhost to MEDICAL FAIR ASIA, as it

makes a much anticipated returnfrom 31 August to 2 September2016 to be held at a new venue –the Marina Bay Sands Singapore.

The 11th instalment of the interna-tional exhibition on Hospital,Diagnostic, Pharmaceutical, Medical& Rehabilitation Equipment &Supplies continues its proudtradition of show-on-show growth,with an anticipated participation of1,000 exhibitors from 45 countries,20 national pavilion and countrygroups and an expected attendanceof 15,000 qualified trade buyers anddecision makers from across Asia,making it the largest MEDICAL FAIRASIA trade event yet.

Organized by Messe DüsseldorfAsia, MEDICAL FAIR ASIA isSoutheast Asia’s most definitiveevent for the medical and healthcareindustry, bringing together all facetsof the industry for networking,sharing of best industry practices, aswell as products, services andsolutions development. Part of

MEDICA – World Forum forMedicine, a global series of medicalevents, MEDICAL FAIR ASIA’scontribution and growing relevanceto the region and its associatedindustries is further underlined bythe endorsement and continuedsupport it receives from hospitalsand medical associations all acrossAsia as well as from the SingaporeTourism Board and the SingaporeExhibition and Convention Bureau.

WHERE HEALTHCARE CONNECTSWITH TECHNOLOGYMEDICAL FAIR ASIA is well posi-tioned to be the No.1 procurementstage for industry professionals toexperience new and innovativetechnologies, solutions, productsand services.

At the 2016 edition, new disruptivedigital healthcare solutions such asremote and wireless healthcare, ITplatforms, wearable devices, smartermedicine and healthcare analyticsare also expected to be showcasedby participating exhibitors.

Focused on equipment andsupplies for the hospital, diagnostic,

pharmaceutical, medical andrehabilitation sectors, the eventcontinues to raise the overallcapabilities and spur the growth ofthe region’s medical and healthcaresectors to meet the changingdemands in both the public andprivate sectors, driving the nextwave of healthcare modernization.

SYNERGISTIC CO-LOCATIONWITH MEDICAL MANUFACTUR-ING ASIA 2016

MEDICAL MANUFACTURING ASIAwill return for its 3rd edition and runsynergistically with MEDICAL FAIRASIA 2016. Focused on the medicaltechnology and medical manufactur-ing sector, the trade fair is jointlyorganized by Messe Düsseldorf Asiaand the Singapore PrecisionEngineering & Technology Associa-tion (SPETA).

The synergistic qualities of MEDICALFAIR ASIA 2016 and MEDICALMANUFACTURING ASIA 2016 bodewell for exhibitors and visitors alikeas they gain access to a diverse mixof high quality products andservices.

MEDICAL FAIR ASIA 2016THE HALLMARK EVENT FOR ASIA’S MEDICAL AND HEALTHCARE SECTOR

COMING TO YOU SOON IN SINGAPORE31 Aug – 2 Sep 2016 | Marina Bay Sands, Singapore

ASIA - AT THE SPOTLIGHT FORINVESTMENT, INNOVATION ANDGROWTH IN HEALTHCARE

The dynamic healthcare landscapeacross the Asia is riding on a stronggrowth momentum in areas of newentities, investments and productswith the accelerated evolutiondriven by innovation and opportuni-ties afforded by this region.

As the medical and healthcaresector continues on the robustgrowth in Asia, MEDICAL FAIR ASIAwill continue to be the preferredstrategic business platform forregion’s medical and healthcareindustries.

With exhibition spaces filling fast,interested exhibitors are encouragedto submit their space booking formsfor MEDICAL FAIR ASIA 2016 at theearliest opportunity.

For more information on the tradefair, please visit :

www.medicalfair-asia.com or

[email protected]

4 | November-December 2015 | Medical Device ASIA

Hearing Regulatory Updates regarding Registration Requirements, Labeling Requirements and Collaboration in China, ASEAN, Japan, Korea and other Asia Pacific Countries

Analyzing the Cooperation and Challenges for Market Access Strategy and Distribution of Medical Device in Asia Pacific Region

Understanding Supplier Chain Management on Process and Products Changes and Security Management throughout

Managing Requirements and Strategies in Clinical Trials across the Asia Pacific Region

Managing Quality Regulatory Compliance for Medical Device Enterprises and GMP Standards in Different Jurisdictions

Sharing Future Trends of Medical Device with Drug and Health Economics Situation

Current Status and Background of Medical Equipment Leasing and M&A in Medical Device Market

Exploring the Best Platform for Experience Sharing and Networking Opportunities with Industry Peers and Experts

Contact UsMs. Vivi Ye

Tel: +86 21 5258 8005 * 8106 E-Mail: [email protected] Web: www.duxes-events.com/mdap2/

Buyers from Japan, Taiwan, Singapore, and Vietnam recorded significantgrowth. It is an indication of Asia’s strong demand for medicalsupplies and services,” said HKTDC Deputy Executive Director

Benjamin Chau. “An ageing population and increased health consciousnessare also factors boosting the demand for healthcare equipment in theregion.

Silver Market

According to the United Nations, it is estimated that there would be twobillion people aged 60 or above by 2050, accounting for 21 per cent of theworld’s total population. Reflecting this trend, many buyers attended the fairto source rehabilitation products and those targeting the silver market.Australia’s Comfort Mobility Pty Ltd. is a manufacturer of medical fixtures andsupplier of healthcare equipment for the elderly. The company’s Director,

John Minchenberg, said: “This is ourfirst visit to the Medical Fair. We’vefound a potential supplier fromHong Kong for electrical wheel-chairs. We will have further discus-sions with them on pricing andother details. If everything goessmoothly, we could see four to sixcontainers worth of business ayear.”

First-time Czech buyer MeyraCr s.r.o. is a producer of sports andelectrical wheelchairs. The companyalso sources a range of traditional

wheelchairs and medical devices forelderly care and rehabilitation, fromdifferent countries. The CEO of thecompany, Jan Býma, said he hadshortlisted five potential suppliersfrom the Chinese mainland, Taiwanand Korea. “Products that we areinterested to source include:wheelchairs that help users standup, foldable wheelchairs, walkingaids as well as bathtubs and toiletseats for the elderly. Our initialorders are estimated at US$30,000to US$50,000.” He said the fairshowcased a broad range ofproducts and was a good place forsourcing.

Lin Chin Hsing, Manager of Taiwan’sSilver Care Health ManagementConsultants Ltd., was optimisticabout business prospects formedical equipment and productsfor the elderly in Taiwan. Heattended the fair to look for moreproduct choices. “The HKTDC’sbusiness matching service is veryuseful. I am already in contact withseveral Hong Kong and Chinesemainland suppliers for differentproducts, such as a stair-climbingwheelchair, electrical wheelchair, anda pain-relieving device for women inlabour. The visit has been veryrewarding.”

Boai Enterprise Group (China)operates nearly 100 hospitals andmedical institutions offering general

International Medical Devices andSupplies Fair EndsNEARLY 10,000 BUYERS; STRONG DEMAND FOR ELDERLY CARE PRODUCTS

“The sixth Hong Kong International Medical Devices and Supplies Fair (Medical Fair 2015) ended, having welcomed nearly 10,000 buyers

over the three-day fair period, up 3.6 per cent year-on-year. Organised by the Hong Kong Trade Development Council (HKTDC) and co-organised by the

Hong Kong Medical and Healthcare Device Industries Association, the fair saw encouraging growth in buyer attendance from Asia as well as strong interest

in products targeting the silver market.”


and specialist services. Zhu Juhong,Assistant to the President of theGroup, said the fair had helpedthem learn more about the latesttechnologies and products, and thatinitial contacts had been made withseveral potential suppliers fromHong Kong, Singapore and Canada.

Product Launch

The Medical Fair is an importantplatform for many manufacturers andsuppliers to promote their latestmedical technology and productsto overseas buyers. The fairwelcomed a record of more than250 exhibitors from 11 countriesand regions this year. ID Infinity Ltd.showcased its dental floss tool,Toothbat, as well as its latest WOWand Childers series. Director GordonLam said the response they receivedhad exceeded earlier expectations.

“A lot of buyers have expressedinterest in our products; we havesold all 500 sets of products in lessthan two days. We are now takingpre-orders. Aside from Hong Kongbuyers, we have also establishedties with buyers from the Chinesemainland, Japan, Costa Rica, India,Korea, Thailand and Australia. Someof them even expressed interest inbecoming our distributors.” Mr Lamsaid he would continue to exhibit atthe Medical Fair to promote thebrand and launch new products.

First-time exhibitor Active FunCompany Limited used the fair tointroduce its trampoline whichpromotes exercise and mobilityamong the elderly. Product ManagerCyrille Guillot said the fair was usefulfor promoting the benefits ofrebound therapy. “Buyers fromdifferent places have been veryinterested in our products. If wewere to offer our products for sale,we would have sold over 100 unitsalready. We will be discussing long-term cooperation with our newcontacts.”

Hong Kong Science and Technol-ogy Parks’ tenant Deltason MedicalLimited showcased the Rex Bionicsrobotic device, which it distributedat the fair. The device uses advancedrobotic technology to help spinecord injury (SCI) patients to stand upand walk around. Service EngineerPete Witherspoon said: “The MedicalFair is an excellent trading platformfor us to meet buyers from aroundthe world and explore opportuni-ties. We have promoted anddemonstrated the robotic device atthe fair and got a good responsefrom many visitors. A Hong Kongbuyer even offered to place anorder immediately.”

Regional Pavilions FosterTrading

This year’s Medical Fair featured two

inaugural pavilions: the Canada Pavilion and the Taiwan Medical and BiotechIndustry Association Pavilion. The Canada Pavilion comprised 11 companies,showcasing medical solutions and health management products andtechnology. Cynthia Carlone, Vice Consul & Trade Commissioner of theConsulate General of Canada in Hong Kong and Macau, said the fair offereda great chance for Canadian companies to explore the Hong Kong marketand expand their presence in the Asia-Pacific region. “We have met manybuyers on the first day, and we are optimistic that our companies will findthe right trading partners here,” Ms Carlone said.

Taiwan Medical and Biotech Industry Association’s Chief Secretary, SidneyLin, said Taiwan’s medical industry has been expanding steadily over theyears. The Association set up its inaugural fair pavilion to help its membersdevelop their presence in the international market. “A number of buyers haveexpressed interest in our products. Several potential customers from theChinese mainland and the UK have even examined some of our devices indepth, and we hope to develop business with them,” Mr Lin said.

To help industry professionals gather market intelligence, the HKTDCorganised a number of seminars during the fair, inviting industry experts todiscuss topics such as the latest medical technology, regulations and markettrends. The concurrent Hospital Authority Convention 2015, one of theregion’s largest healthcare conferences, welcomed more than 5,000healthcare professionals this year, and created strong synergy with theMedical Fair.


The value of the multiplesclerosis therapeutics marketwill rise slowly from $17.2

billion in 2014 to approximately $20billion by 2024, at a CompoundAnnual Growth Rate (CAGR) of1.5%, according to research andconsulting firm GlobalData.“

“The company’s latest report* statesthat this growth, which will occuracross the ten major markets of theUS, France, Germany, Italy, Spain, theUK, Japan, Canada, China and India,will primarily be driven by thecontinued uptake of premiumproducts and an increase intreatment rates as a result of theavailability of novel alternatives.“

“Thomas Parker, MPharmacol,GlobalData’s Analyst coveringNeurology and Ophthalmology says:“The continued uptake of oralDisease Modifying Therapies (DMTs)

that typically have a higher annualcost of therapy and improvedcompliance rates, coupled with anincrease of DMT treatment optionsthat target progressive multiplesclerosis subtypes, will drive growthover the forecast period.“

However, the market is expected toplateau between 2018 and 2020, asthe generic erosion of key brandedproducts, such as Teva’s Copaxoneand Novartis’ Gilenya, offsets theuptake of pipeline agents.”

Despite this, the analyst notes thatsteady growth will resume from2020 onwards, as additionalpipeline products become availablein Western countries.“

GlobalData’s report identifies eightlate-stage drug products that areanticipated to enter the multiplesclerosis therapeutics market during

Multiple Sclerosis TreatmentMarket Value to Reach $20 Billion by 2024

the forecast period, with Roche/Genentech’s ocrelizumab, Celgene’sozanimod, and AbbVie/Biogen’s Zinbryta expected to generate the highestrevenues.

Parker explains: “These efficacious pipeline products are expected to have asignificant impact on the market, as they are likely to be popular with patientsthanks to being oral formulations or requiring a less frequent dosageschedule.

Collectively, GlobalData forecasts that the eight late-stage pipeline productswill claim a 29.8% share of the global multiple sclerosis treatment market by2024, generating combined sales of nearly $6 billion,” the analyst concludes.


21x28.indd 1 12/2/15 11:48 AM

The health economy has excitingtopics on its agenda:Digitalisation, networking and

“wearables” create a dynamic effect

The new set of dates running fromMonday to Thursday has beenwidely accepted by the specialistvisitors of the world’s largestmedical trade fair, the MEDICA 2015,as well as the specialist suppliertrade fair, COMPAMED 2015, beingheld in parallel. Both were wellreceived right from the start this year.“The 19 trade fair halls were intenselyvisited without exception. Theconcentration of the MEDICA +COMPAMED during the normalworking days of the week offers thespecialist audience an even widervariety of travel planning options.This time, that had a positive effecton the well-visited trade fair forums

as well as the accompanyingconferences. Here, the manyprogramme highlights were verypopular on all days,” said JoachimSchäfer, managing director of MesseDüsseldorf GmbH.

From 16 – 19 November, 130,000specialist visitors from around 120nations came to Düsseldorf(previous year: 128,500). Theportion of international visitorsamounted to just over 50 percent, astrikingly large number came fromthe foreign markets of the USA, LatinAmerica and especially from Iran andcountries located in the Arabic-speaking regions. “The MEDICA isand shall remain a top event fordecision-makers across all countryborders,” Joachim Schäfer addedwith respect to the fact that 96percent of the visitors have

decision-making power. For the firsttime, the complete spectrum ofinnovations for out-patient andclinical care were offered by almost5,000 exhibitors from 70 nations toexperts from hospitals, practices,laboratories, the retail sector as wellas from industrial ranks and costbearers (insurance companies) thatare especially relevant with regard toinvestments.

The exhibitors especially benefit to agreat extent from MEDICA’s highlevel of internationalisation on theside of visitors. This is because themedical industry is developing in adynamic and unchanged manner,being particularly driven by theexport business. For the comingyear, the companies organisedwithin the Federal Association ofMedical Technology (BVMed e.V.)

expect an increase in sales of 6.8percent on a worldwide level,whereas growth of 4.3 percent hasbeen forecast for the Germanmarket. For the MEDICA 2015, theindustry associations SPECTARIS andZVEI have confirmed an evidentgrowth of at least six percent fortheir member companies, alsoresulting from the “solid” growthlevels of the business in WesternEurope. In accordance with this, thesales volumes of German manufac-turers is currently at around 27 billioneuros at an export quota of 68percent. Nevertheless, the Germanmarket, which is virtually just outsidethe gates of the MEDICA trade fair,will remain quite lucrative from anindustrial perspective. Following theUSA and trailing right behind Japan,it is considered the third largestmarket for medical technology and

The new set of dates for the

MEDICA and COMPAMEDhave been widely approved – the federal government shows its impressive presence


medical products. Germany alsoscores top marks with its goodhealthcare infrastructure, a goodlevel of care for patients, well-educated medical professionals andhigh standards regarding clinicalresearch.

Gröhe and Wanka provided forpolitical momentum

In order to guarantee this high levelshown in a worldwide comparisonin the future, not one, but twomembers from the ranks of thefederal government used theMEDICA as premium platform fordiscussion and communication ofcurrent political issues. On theoccasion of the opening of theMEDICA 2015, at the 38th GermanHospital Conference, the FederalMinister of Health, Hermann Gröhe,underlined the significance of theplanned hospital structure law toimprove the financial resources ofGerman hospitals. Following this, atthe MEDICA ECON FORUM, he

discussed current health policyissues. On the occasion of theopening of the MEDICA 2015, theFederal Minister of Education andResearch, Professor Johanna Wanka,presented, at the MEDICA HEALTH ITFORUM, the federal government'spioneering funding concept formedical informatics. It focuses onexactly what is still currently lacking inmany cases: Many medical data aresaved, scattered around hospitals,clinics or other medical institutions –often not even in digital form.Federal Minister Wanka highlightedthat due to this, innovative ITsolutions are in demand to providefor improved consolidation of data.“One of the largest subject-matterfocuses of the MEDICA entails thedigitalisation of the medical field.That is why the MEDICA 2015 is theideal place to present the develop-ment concept of medicalinformatics. For us, it mainlyconcerns using medically relevantdata for the well-being of patients. Ifthese data are systematically

evaluated, more precise diagnosesand improved therapies can bederived therefrom as a result."

The digital “revolution” couldbe based on patients

The MEDICA visitors were able to beimpressed with regard to numerousinnovations presented by exhibitorsin the face of the digital futurealready taking shape in very specificways, but also by the lectures andpresentations that were being heldat the MEDICA CONNECTEDHEALTHCARE FORUM (with theMEDICA App COMPETITION) or theMEDICA HEALTH IT FORUM. For thisreason, among other things,projects and IT applications werepresented providing a live connec-tion to the patient, from the hospitalbed into a classroom by means ofthe Internet, tablet PCs and acontrollable robot or also theproject entailing a telemedicalconsultation session to improvemedical care in rural areas.

In particular, “wearables” andsmartphones in combination withspecial health apps which can alsobe used by patients themselveshave the potential of becoming anessential element of networkedhealth in the future. The productinnovations at the MEDICA 2015included the first mobile 22-channelECG system for tablet PCs andsmartphones. The system not onlymakes the diagnosis of arrhythmiaspossible, but also the diagnosis ofcirculatory insufficiency (the earlysigns of a heart attack). A high levelof interest was also shown for amobile analysis tool to measureemotions for the optimum manage-ment of stress or a device similar toa Frisbee disc with a mobiletelephone connection for theprecise analysis of sleep activities –at a sleep laboratory level, but foruncomplicated use under themattress in one's own bed.Everyone was also able to gain animpression at the “WearableTechnologies Show” (in hall 15) of


“where the journey will go fromhere” and what analysis data patientswill possibly be confronting theirphysicians with in the near future.The variety of devices ranges fromlifestyle products, such as fitnesstrackers, to intelligent glasses andhearing devices, all the way to thelatest trend – intelligent patches thatcontinually retrieve physical data, butthat can also administer medicationsin a minimally invasive manner.

In general, the miniaturisation trend inthe field of medical technology iscontinuing. This also applies withreference to devices and systemsthat should only really be used by“professionals in the field”. Thisincludes, for example, extremelycompact devices with sizes that aresuitable for jacket pockets formedical imaging, whereby that canstill be taken to extremes. This isbecause an ultrasound device waspresented at the MEDICA 2015consisting of a mere transducerhaving a connection to a tablet PCwith a matching app. Also new: asystem with a wireless transducer forparticular freedom of movementduring ultrasound examinations.

Supporting programme is wellreceived at an internationallevel

During the accompanying confer-ences, a subject of discussion wasalso made concerning how suchmedical technology innovations canbring about an optimum level ofbenefit within the scope of the dailyroutine at many medical institutions.In particular, these included theDiMiMED for military and disastermedicine, which also receivedgood international participantfeedback with its presentations heldin English, as well as the MEDICAPHYSIO CONFERENCE conceivedespecially for physiotherapeutictreatment concepts.

The MEDICA EDUCATION CONFER-ENCE, organised by the GermanySociety for Internal Medicine (DGIM)and Messe Düsseldorf, offeredmany interdisciplinary and interna-tional programme highlights withinthe scope of 56 events with 168speakers from Great Britain, theNetherlands, Sweden, Austria and

Poland, among others. Theconnection between science andmedical technology was thecommon theme of the presenta-tions. Thereby, with topics such assurgical robotics,gerontotechnologies, image fusionand interventional therapies, theselect focuses of the four confer-ence days ideally built a bridge tothe innovations of the MEDICAexhibitors and were well receivedby the participants,” said theconference president, ProfessorHendrik Lehnert, confirming thesubject-matter focus in the conceptof the continuing education event.

Once again, the 38th GermanHospital Conference, which wasaccompanied in a complimentarymanner this time by the internation-ally oriented 3rd European HospitalConference, was on the one handdedicated to health policiesaccording to the motto “Reform2015 – conceived from theperspective of patients”. On theother however, “substantial issues”were also dealt with within theprogramme for approx. 1,900participants from the field of hospitalmanagement. During the sessions ofthe IT initiative “ENTSCHEIDERFABRIK”,it was shown how companysuccess can be increased by meansof using IT. For example, a currenthospital project that was presentedis dedicated to processoptimisation in emergency depart-ments, which are considered to becost-intensive – taking intoconsideration all relevant “interfaces”by means of improved communica-tions and data exchange (e.g.between the A+E unit, theoperating theatre and hospital bedplanning).

Suppliers as partners for theentire supply chain

Being the leading trade fair forsuppliers of the medical technologyindustry and being held for the firsttime during the course of four days,the COMPAMED took place inconnection with the MEDICA alreadyfor the 24th time. A record numberof 779 exhibitors presentedtechnology solutions and servicesfor the entire medical technologysupply chain to the 18,800 specialist

visitors in halls 8a and 8b – from the development to approval, all the way tomass production and sales, as well as spare parts handling. For example, thejoint stand of the IVAM – the German Industry Association forMicrotechnology – as well as both specialist forums integrated into theCOMPAMED made the continuous miniaturisation a subject of discussion,entailing increasingly more compact and, at the same time, more complexsystems. Highlights at the COMPAMED 2015 include, among other things,smart sensors for use in “wearables”, microsystem technology applicationsfor intelligent implants or also printed electronics (made a topic of discus-sion in a session of the IVAM forum by the VTT Technical Research Centre ofFinland).

Dates of the next MEDICA and COMPAMED in Düsseldorf: 14 - 17 Novem-ber 2016Messe Düsseldorf GmbHPress and Public Relations MEDICA und COMPAMED 2015Martin-Ulf Koch / Larissa BrowaTel. +49-(0)-211-45 60-444/-549FAX +49-(0)-211-45 60-8548E-mail. [email protected]


Air Liquide Medical SystemsPvt. Ltd. (ALMS), themedical equipment

subsidiary of Air Liquide Healthcare,celebrated today, in the presence ofthe Ambassador of France in India,H.E. François Richier, their 7th year ofmanufacturing activities in India. Onthis occasion, ALMS unveiled theirnew Orion G ventilator, the first CEmarked ventilator to be manufac-tured in India for both domestic andinternational markets.

The launch of this new ventilator fallswithin Air Liquide Medical Systems(ALMS) strategy to bring high-technology devices to the domesticHealthcare Sector. Orion G is indeedthe latest of a complete range of 7types of ventilators in India pro-posed by ALMS in India. Besides

ventilators, ALMS also manufacturesCE marked Medical Air Compressorsin India which are now exported tovarious countries.

Orion G ventilator, developed withthe support of ALMS teams inFrance will meet the requirements ofventilators in ICU, emergency andpost-operative wards. It will featurecolor touch screen and batterybackup. Orion G will be manufac-tured at the ISO 13485 certifiedALMS plant in Chennai, Tamil Nadu,will be in conformity with the latestEuropean norms.

“We strongly believe in empoweringour teams in India in order todevelop our manufacturing and R&Dactivities also with the objective ofexporting certified devices

Air Liquide Medical Systems look far aheadafter celebrating their 7th Make in India anniversary

worldwide” said Mr. Jean-MarcGiner, Managing Director of AirLiquide Medical Systems.

About Air Liquide Group:

Air Liquide Healthcare suppliesmedical gases, home healthcareservices, hygiene products, medicalequipment and specialty ingredi-ents. In 2014, it served over 7,500hospitals and 1,2 million patients athome throughout the world. TheGroup’s Healthcare businessreached • 2,570 million in revenuesin 2014, with the support of its12,000 employees.

Air Liquide Medical Systems Pvt Ltdis a company of the Air LiquideGroup and has been present in Indiafor the past 34 years with sales and

services facilities in more than 20cities. Along with these manufactur-ing activities, ALMS also providesextensive services to its clients andmaintains about 6,000 ventilators allover the country. ALMS has anefficient in house R&D departmentwhich specializes in hardware,software, medical design andplastics.

About Business France:

Business France is the nationalagency supporting the internationaldevelopment of the Frencheconomy, responsible for fosteringexport growth by French busi-nesses, as well as promoting andfacilitating international investment inFrance. It promotes France’scompanies, business image andnationwide attractiveness as aninvestment location, and also runsthe V.I.E international internshipprogram. Founded on January 1,2015 through a merger betweenUBIFRANCE and the Invest in FranceAgency, Business France has 1,500personnel, both in France and in 70countries throughout the world,who work with a network of public-and private-sector partners.

For further information, please visit:http://en.businessfrance.fr

For further information, pleasecontact:S. Sivakumar,Managing Director, Air LiquideMedical Systems PVT Ltd.Plot No.36, Annai Indira Nagar |Okkiyam Thoraipakkam | Chennai600097| INDIATel: +91 (0) 44 4385 11 16/17 | Fax:+91 (0) 44 2458 00 43 |www.airliquidemedicalsystems.in

Speakers, from left to right: Mr. Siva Kumar, Managing Director ALMS Pvt. Limited India, Jean-Marc Giner, ALMS ManagingDirector, Rohith Girish, Marketing Director, Air Liquide Medical Systems India


Counterfeit products enteringthe supply chain is a seriousproblem that has long been

plaguing the pharmaceuticalindustry. These drugs can containineffective or even harmful ingredi-ents thereby posing a very danger-ous threat to consumer safety.Additionally, counterfeit drugs costthe pharmaceutical industry billionsof dollars each year in lost jobs andrevenue, and can erode pricelesscommodities – brand reputation

and consumer trust.

These safety concerns have givenrise to various regional and globalregulations requiring strict productserialization that allow products tobe quickly and accurately tracedthroughout the supply chain (See:“Strict Rules & Regulations”). Withthat in mind, now is the time forpharmaceutical manufacturers toleverage coding and markingsolutions within their packaging

operations to help preventcounterfeiting.

In order to make the best choicespossible, there are key factors toconsider: performance and lineintegration. High-quality, permanentcoding on a variety of packagingintegrated into existing operationswill allow pharmaceutical manufac-turers to ensure regulatory compli-ance and consumer safety, whilealso maintaining manufacturing

efficiencies and protecting brandintegrity.

Coding & Marking SolutionsThe mandatory information requiredon pharmaceutical packaging to becompliant with regulations repre-sents a significant increase fromcurrent coding. Additionally, it isimportant to consider that theinformation must be both humanand machine readable (See: “StrictRules & Regulations”). While there is

Pharmaceutical Packaging Serialization 101

By Richard Nemesi, Global Vertical Manager for Pharmaceutical and Medical Devices at Videojet Technologies

HOW MANUFACTURERS CAN MEET CONSUMER SAFETYREGULATIONS, PROTECT THEIR BRAND AND MAINTAINPROFITS


a wide range of available coding andmarking technologies, the goodnews is that recent advances haveyielded state-of-the-art solutions tomeet the challenges of thepharmaceutical industry, includingThermal Inkjet (TIJ), Laser, Print &Apply Labeling (LPA), ThermalTransfer Overprinter (TTO), andContinuous Inkjet (CIJ).

TIJ is generally used to printtraceability information including 2DDataMatrix codes – the standardcode carrier for a wide range ofregional and country-specificserialization requirements – ontopackaging commonly found inpharmaceutical operations such ascartons, labels, blister foils, andpouches and barrier materials. Theprinter’s fire tiny ink drops throughfine-gauge nozzles onto packagingas it passes a printhead or cartridge.This system is used for high-resolution, ink-based, non-contactprinting, utilizing heat and surfacetension to move ink onto a packagesurface.

Traditionally, TIJ was well-suited toprinting high-quality text and barcodes on porous substrates,ensuring that complex and detailedcodes are clearly readable fordownstream verification. However,recent innovation in TIJ technologyhas made it possible to code on arange of non-porous substratesincluding films, foils, plastics andcoated stocks.

Laser marking can be used to print2D bar codes as well as humanreadable codes. Laser is an idealchoice for creating permanentcoding on pharmaceutical packag-ing such as cartons, bottles, labels,vials and ampules, tubes and blister

foils. Laser marking uses a beam ofinfrared light focused and steeredwith a series of carefully controlledsmall mirrors to create marks wherethe heat of the beam interacts withthe packaging surface.

TTO is good for marking flexiblepackaging such as pouches andbarrier materials, offering high qualitycodes from date, lot, and timestamps to more complex codessuch as bar codes, use warnings,and ingredients lists. TTO systemsuse a digitally controlled printheadto precisely melt ink from a ribbondirectly onto flexible films, providinghigh-resolution, real-time prints.Extremely versatile, CIJ systems canbe used to print on nearly anypackage type or product shape andis suited for a wide variety ofpackaging, including cartons,bottles, labels, vials and ampules,tubes, blister foils, pouches andbarrier materials, and stick packs. CIJtechnology is used for fluid-based,non-contact printing of up to fivelines of text, linear and other 2Dbarcodes. Fast print speeds and arange of application-specific inksmake CIJ a strong option forpharmaceutical packaging.

To meet increased demand for highgrade coding downstream on thepackaging line, such as bundles andcorrugate cases, Print and ApplyLabelers (LPA) automatically printsand places labels of various sizesonto packaging. LPA can helppharmaceutical manufacturersensure accurate label placement andhigh resolution coding.

Substrates & SolutionsUnderstanding the wide range ofadvanced coding and markingsolutions is the first step towards

making an informed investment incoding and marking technology.Next, comes the critical part –pairing the right technology with theright application.

Cartons/Carton CodingCartons are one of the mostcommon packaging formats usedby pharmaceutical and medicalproducts. Marking these cartonswith high-quality human andmachine readable codes is generallya critical element of any company’straceability plan.

TIJ is the most common choice forcarton coding. It is typicallyadvantaged in terms of throughputfor dense coding applications,because speed is only governed bydesired print resolution and the firingfrequency of the resistors; thecomplexity of the code does nothave an impact. Some vendorsprovide high-performance TIJ inks,which can further improve inkadhesion and contrast.

Laser coding on cartons is anothercommon selection, because of thesimple and clean method of markingtext, bar codes or images whileusing virtually no consumables. Lasercreates permanent codes and canmark multiple adjacent productsduring indexing.

Also good for cartons, CIJ codesadhere to nearly all common cartonmaterials, including those with non-porous or water-resistant coatings.

Bottles/Bottle CodingAn extremely common pharmaceuti-cal packaging format, bottles can becoded in numerous locations. Forexample, visible and ultraviolet (UV)or infrared (IR) visible marks can be

made to the side, bottom, label orcap of a bottle.

CIJ printers work with a wide rangeof visible inks, UV- and IR-visible inks,and invisible inks for covert codingto aid brand protection.

In addition, laser can be an effectivemethod for creating indelible marksdirectly on the surface of a bottle orcap.

Label MarkingMarking directly on labels frequentlyrequires integration with labelingequipment, which yields highquality, precisely positioned codes.TTO offers a simple method ofdirect contact coding on labelsbefore application to the bottle orpackaging. Seamless integration androbust bracketry are crucial. Capableof high resolution printing, TTO isideal for bar codes, high contentcodes, and product information.

For this application, the simple CIJset-up includes integration of thesmall marking printhead and aflexible umbilical hose into labelingequipment. With a wide variety ofinks, CIJ enables printing on bothpaper and plastic label stocks,offering color variety depending ondesired contrast.

TIJ is another ideal method formarking labels prior to application,allowing for high code quality andcontrast while delivering complex2D or DataMatrix codes. A smallprinthead integrates easily into labelapplication equipment.

Laser marking systems offer thecapability to print crisp codes ontolabels irrespective of original pre-printed dark marked windows.


Vial & Eye Dropper MarkingVial marking and eye dropper bottlemarking is a challenging applicationdue to the small surface size andreduced radius. This is bestachieved with a coder integratedinto the original equipmentmanufacturer (OEM) packaging thathas been specifically designed forthis type of package.

CIJ is an effective marking technol-ogy for glass vials. Today’s CIJs usesophisticated software that can helpensure high drop placementaccuracy, critical for small 2D codes.Autoclave resistant inks, as well asvisible and UV inks can be used forbrite stocking applications. CO2,fiber and UV lasers can also be usedfor the level of precision required forvial and eye dropper bottle marking.Fiber lasers can be utilized to markon the vial crimping.

Flexible Material MarkingBlister lidding foils, Tyvek® and otherbarrier materials, pouches and avariety of flexible materials are usedin packaging pharmaceutical andmedical products. Coder integrationin packaging systems is oftenneeded for reliable, high qualitycoding of flexible packaging.Porous TIJ inks are optimal forprinting on porous and semi-porousmaterials. Multiple printheadsmounted in an array or integratedinto a traversing system can be usedfor marking web-fed materials.

Another viable choice for flexiblematerial marking, TTO can beintegrated into the web handling ofpackaging systems with bracketryspecific to each packagingequipment OEM. TTO offers highresolution, wide format printing ofalpha-numerics, bar codes, andsimple one-color icons.In addition, laser marking can beused on a variety of blister lidding

materials. A properly integrated lasermarking system can easily markmultiple lanes with high qualitycodes.

Case CodingEffective supply chain managementand traceability only works withhighly accurate, clearly readableinformation on shipping cases. Forcase coding, the right solutiondepends on factors includingsupply chain partner requirements,and local standards and regulations.LPA is the standard way to identifyproduct for delivery to supply chainpartners. Automated labelingsolutions can significantly reducemislabeling as it is faster, moreconsistent, and has less potential forerror than labeling by hand.

TIJ is also used in high resolutionprinting directly onto cases. Its’ highresolution printhead can be stackedto create large images on the sidesof cases and other poroussubstrates.

In-line IntegrationThe next step is knowing where andhow to best implement serializationsolutions. Coding solutions can beinstalled as components of broader

packaging machines such ascartoners, starwheels, bottlers, andthermoformers, or they can beretrofitted into existing equipment.Incorporating coding solutionsproperly along the packaging linecan go a long way in increasing theoverall efficiency of a manufacturingoperation.

CartonerCoding can take place in severallocations within the equipment,integrated into the cartoner, itself, oron the outfeed conveyor. Keep inmind that printing can also takeplace upstream on the primary packas required. Integrating the printerinto a cartoner provides greatproduct control and the additionalbenefit of applying the code afterthe product has been inserted intothe carton.

Sidegrip ConveyorThe sidegrip conveyor can be usedto mark visible and covert codes onthe top or bottom of bottles.Downstream code verification canbe easily accommodated while thebottle is engaged by the conveyor.There are distinct advantages toprinting on the bottom of the bottle,an inherently more protected spot

which does not consume spacethat is visible when a product is onthe shelf.

Bottle LabelerSeveral different coding technolo-gies can be utilized for contact ornon-contact marking of the labelbefore application. Precise labelcontrol can be used to facilitatehigh-quality alphanumeric and barcode printing.

Vial/Ampule StarwheelWhen placing traceability codesonto small pharmaceutical packaging(less than 2 cm high) placementaccuracy is key. The highly precisemotion of the starwheel is ideal forthis application. Code can also beprinted on the top, bottom or sideof vials and ampules, allowing forcode density in a small space.

CheckweigherThe checkweigher’s uniqueperformance properties such asprecise material handling at highproduction speeds can be used toimprove overall print and DataMatrixquality.

ThermoformerA thermoformer applies and seals


thin-gauge plastic sheeting toprotect a product, such as apharmaceutical blister pack. Precisemechanical and controls integrationmake the thermoformer a strongchoice for high quality marking onweb-based materials, includingblister lidding foils and other barrierfilms.

Aside from the various points ofintegration along the packaging line,there are other factors to consider.Large pharmaceutical manufacturersutilize several different applicationson separate lines (i.e. cartons, vials,bottles, etc.) requiring variouspackaging technologies. In addition,regional packaging preferencescome into play. While the US prefersbottles, blister packs are popularglobally. Additionally, once the rightcoding solution has been specifiedand integrated, it is time to focus onefficient and effective control.Centralized software managementcan be utilized that includes touchscreen with interface and a commonlook and feel for ease-of-use.As counterfeit drugs continue topose a growing problem for thepharmaceutical industry, regulationsmandating the serialization ofpharmaceutical products are on therise.

Pharmaceutical companies are underintense pressure to comply withcoding and marking requirementsdesigned to increase traceabilitythroughout the supply chain. Theultimate goal of total transparencybetween all supply chain partnerswill ensure product authenticity,protecting consumer safety and – asa by-product – brand reputation.However, beyond mandatorycompliance, pharmaceuticalcompanies have financial-basedconsiderations that cannot beignored. Manufacturing efficienciesmust remain high in order to maintainthe bottom line. To help ensure thebest coding and marking solutionspossible, manufacturers need a firmgrasp on the wide range oftechnologies, based on codingneeds (i.e. 2D, DataMatrix, etc.), aswell as packaging types andsubstrates. For the highest level ofefficiency, the solutions must thenbe properly integrated into existingoperations. While it might seem like

a daunting task, experiencedproviders are prepared to help youunderstand how the puzzle fitstogether, ensuring productauthenticity, regulatory compliance,and overall operational efficiency.

SIDE BARStrict Rules & RegulationsIn the US, the Drug Supply ChainSecurity Act (DSCSA) was signedinto law November 2013 settingnew federally mandated require-ments for traceability of pharmaceu-tical products throughout the drugsupply chain. The initial phase of thismulti-faceted act began January2015, requiring manufacturers,wholesalers, and re-packagers toshare batch-level information,including transaction information (TI),transaction history (TH), andtransaction statements (TS) as drugsmove along the supply chain. Forphase one, paper documentationwill be sufficient in order to meetrequirements for compliance. Thisvital information will be conveyed tothe pharmacy level, ensuring quickand accurate product authenticityverification, also allowing for theimmediate quarantine or investiga-tion of a suspect product

Moving into phase two, byNovember of 2017, productinformation will be required on drugproduct packaging for serialization,marking pharmaceutical productswith a unique product identifier that

includes its National Drug Code(NDC) or Global Trade IdentificationNumber (GTIN), unique to theproduct, based on chemicalcomposition and does not changeunless the product is reformulated.Additional required informationincludes serial number, lot numberand expiration date. This informationmust be easily readable by bothmachines and people.Finally, by 2023, the third phase willfeature complete interconnectivity,meaning shared ownership of databetween all supply chain partners,allowing for full traceability ofpharmaceutical products back totheir origin. This concept is knownas “cradle to grave” traceability.

Not limited to pharmaceuticalproducts, these serializationrequirements include medicaldevices, as well. In 2013, the FederalDrug Administration (FDA) passedlegislation mandating that mandatesa Unique Device Identification (UDI)code on most medical devices inthe US.

About the Author:Richard Nemesi is Global VerticalMarketing Manager for Pharmaceuti-cal and Medical Devices at VideojetTechnologies. His main responsibili-ties at the company are to develop adeep understanding of globaltrends and customers’ needs withinthe sector, create marketing contentto support sales efforts and provide

counsel to product developmentteams on equipment functionality.Prior to Videojet, he was a SystemsSales Specialist in the Systems andTechnology Group at IBM.

About Videojet Technologies:Videojet Technologies is a world-leader in the product identificationmarket, providing in-line printing,coding, and marking products,application specific fluids, andproduct life cycle services.

Our goal is to partner with ourcustomers in the consumerpackaged goods, pharmaceutical,and industrial goods industries toimprove their productivity, toprotect and grow their brands, andto stay ahead of industry trends andregulations. With our customerapplication experts and technologyleadership in continuous inkjet (CIJ),thermal inkjet (TIJ), laser marking,thermal transfer overprinting (TTO),case coding and labeling, and widearray printing, Videojet has morethan 325,000 printers installedworldwide. Our customers rely onVideojet products to print on overten billion products daily. Customersales, application, service, andtraining support is provided bydirect operations with over 3,000team members in 26 countriesworldwide. In addition, the Videojetdistribution network includes morethan 400 distributors and OEMs,serving 135 countries.




Prithvi, Akash, Jal, Agni and Vayu– These are the five elementsthat we are made up of. Prithvi

(Earth) and Akash (Sky) are beyondour control, Jal (Water) & Agni (Fire)are already taken care of in bestpossible ways. What about Vayu(AIR)? Air is the most importantsubstance going into our body fromoutside.

During the developing years (0 to 13years) of a child, the impurities in AIRare ignored by most, causing thebiggest damage to our health withseveral AIR BORNE DISEASES. Thehomes that we build today, in-spiteof our perceived best architecturaldesigns, we fail to comply with thisbasic need.

Sharp’s revolutionary air purifierenabled with its Plasma Cluster IonTechnology could be a real saviour.It creates forest fresh air bygenerating the same level of Positive& Negative Ions found in naturalenvironments like forest, resorts,parks which in the process createHydroxyl Radical (called Nature’sDetergent) thus killing harmfulsubstances not only from the air butalso from the surface and eliminatesbad odour.

Unlike other Air Purifiers, employingpassive method that requires the airto pass through a set of filters toclean and recycle the air, Sharpcomes with an Air PurificationSystem as it incorporates an activemethod that reduces suffocation/staleness by generating fresh air.Plasma cluster Ion TechnologyMimics Nature by generating Positiveand Negative Ions which arereleased into the air then reachesout to the surface and the cornersof the room destroying infection

causing germs and irritants.

“Several health authorities haverecognized that certain types of airpurifiers are beneficial in reducingthe amount of Particulate Matter 2.5in the room.

During my studies of all Air Purifica-tion techniques, I have observedthat the Sharp Air Purifier equippedwith Plasmacluster Ion Technology ismuch superior in terms of perfor-mance, reliability and certifications.

Proper ventilation and allowing direct

Sharp’s Revolutionary Air Purifiers HelpsPrevent Airborne Diseases

sunlight in interior spaces are equally important steps towards improving airquality.” said Dr Rajarshi Bhattacharyya, National Head of The Times Founda-tion.

Imagine a Petrol Engine running on a mixture of Petrol and Kerosene! If webreathe AIR and POLLUTANTS together, our Immune System is challenged,gets tired and the performance gets affected.

We easily take Doctors’ assistance, who prescribes several expensive andharmful antibiotics to fight the common flu etc, if we rethink and usePREVENTION than CURE for airborne diseases, we might look forward to bea healthy nation.

Breathing fresh air for at least 8 to 10 hours a day, will nourish the cardiovas-cular system and rest the Immune System thus giving the stamina and energyto fight diseases while in challenging environments.


Rigel SafeTest 60

New Rigel Safetest 60 Provides Fast And Effective Testing Of General Purpose Medical Equipment

infusion pumps, CPAP’s, centrifuges and other similar equipment that does not require patient lead testing.

As such, the SafeTest 60 is suitable for electrical testing to ensure compliance with a range of international safety standards including leakage testing to IEC 60601, IEC 62353, IEC 61010 and NFPA-99.

In addition, to meet the needs of some specific types of equipment, the unit also has the capability to carry out insulation testing in line with IEC 62353 and accurate high current, low energy earth bond testing to both IEC 62353 and IEC 61010.

In all cases, full manual control means only those specific tests that are required can be carried out, with minimised power breaks and full control of power cycles helping to ensure that testing is carried out quickly and efficiently – without any compromise in accuracy or integrity of testing.

As part of the new streamlined approach to carrying out electrical safety tests, an automatic warning of secondary earth/ground paths ensures that users are made aware prior to invalid results being obtained, eliminating time consuming re-tests and ensuring correct and valid results are provided first time.

The new Rigel SafeTest 60 is available in a wide range of power supply configurations to meet standard local operating conditions around the world.

The new SafeTest 60 forms part of a comprehensive range of high performance specialist biomedical test equipment from Rigel Medical.

Full details at www.rigelmedical.com/safetest60.

The new Rigel SafeTest 60 is a compact, robust and reliable safety analyser that

is particularly well suited to high volume testing demands, with a simple colour coded user interface, push button operation and the fast step-through of test routines.

The general purpose tester includes a comprehensive range of safety tests for hospital and medical equipment such as medical beds and chairs, operating tables, hoists,

Rigel has introduced a new handheld safety analyser for the routine electrical testing of basic medical and laboratory equipment.

Biomedical Test Equipment from Rigel Medical

With over three decades of experience, Rigel Medical manufactures a comprehensive range of advance technology Biomedical test equipment, including a dedicated range of Electrical Safety Analysers, all-in-one Vital Signs Simulator, NIBP Simulator, SPO2 Simulator, ECG Simulator, Defibrillator Analysers and Ventilator Testers.

Rigel Medical was the first company to produce a dedicated electrical safety analyser to meet the IEC601 requirements and has since expanded its product offering to a complete range of biomedical test equipment. As an established and respected producer of safety analysers, our products offer the latest technologies such as incorporating Bluetooth and RFID capability, whilst our latest medical safety analyser is using a new test method to accurately measure earth / ground bond resistance at lower currents.

Our biomedical test equipment which includes; safety analysers, function testers and vital signs simulators help biomeds (BMETS), medical physics staff, biomedical and service engineers to comply with strict regulatory guidelines for medical electronic equipment, designed to meet IEC 60601 and the newly published standard IEC62353.


CERTIFICATION““SEKOLogistics’ European MedTeccontrol tower has been

awarded ISO 13485 certification, thefoundation for manufacturers toaddress medical device directives,regulations and responsibilities.““ISO13485 is the known and trustedquality standard in the medicaldevice industry and is adopted byauthorities, suppliers and manufac-turers around the world to demon-strate their commitment to protect-ing the safety and integrity ofmedical devices.““SEKO MedTec isone of SEKO Logistics’ biggest andfastest-growing businesses andprovides highly specializedsolutions focused exclusively on themedical device industry. Thisincludes dedicated program

management for demonstrationequipment, finished goods andreturns, as well as contract logisticsand fulfillment services. SEKO’sengineering, transportation andsoftware services for the industry arebacked up by control towers,knowledgeable staff, and dedicatedclean rooms and facilities.““In theU.S., SEKO has also achieved ISO13485 certification at its U.S.MedTec control tower located inState College, PA as well as for itsMedTec warehouses and hubs inCosta Mesa, CA, Pittsburgh andBaltimore.““Robert Shearer, ManagingDirector of SEKO MedTec, said:“Quality and compliance underpinseverything that happens in themedical device sector and thiscertification is an extension of SEKO

Logistics’ specialization in thisimportant and strictly-regulatedindustry. We continue to innovatewith sophisticated integratedlogistics solutions and software forthe medical industry. Gaining ISO13485 certification for our EUMedTec operation, coupled with fullcertification of all of our U.S.MedTec sites provides our currentand potential clients with theknowledge that their products arehandled to the highest standardsacross both continents.

About SEKO

MedTec““SEKO MedTec FieldServices include:““• Deliveries(forward), Returns (backward),Demos (forward &

backward,““constantly moving) “•Pick-up, delivery, set-up, installation,de-installation services “• Trained &certified delivery personnel “•Customized Standard OperationProcedures “• Post event surveys/questions “• Technical/Power-upservices “• Managed network ofspecialized providers““MedTecValue-Added Hub Services include:“• Decontamination “• Service/Repair “• Kitting/Replenishment “•Quality & compliance records(patient data) “• Contract Mfg “•Crate design / production““AboutSEKO Logistics “We provide a suiteof logistics services which enableyou to use your supply chain as acompetitive differentiator. As acustomer centric organization, weare powered by the expertise of ourpeople and our in-house-devel-oped, best in class, customizabletechnology.

It is this combination which givesSEKO its strength. With over 120offices in 40 countries worldwide,SEKO’s unique shareholdermanagement model enables you tobenefit from our specific industrysector expertise, coupled with vitalin-country knowledge andunparalleled service at the local level.

This unique model provides youwith:• Hands-on service andsupport “• Personal relationships “•Creative, customized solutions “•Responsiveness and reliability “•Flexibility and consistence““We havea flat management structure, with justthree layers between you and theCEO, making us ‘fast on our feet’ indelivering solutions that can meetyour exact requirements.

This lean and nimble structureincreases our decision-makingspeed and gives us an ability toimplement customized solutionswhich far exceed those of ourcompetitors. For more informationvisit our websitewww.sekologistics.com

SEKO LOGISTICS’ EUROPEAN AND U.S.MEDTEC OPERATIONS AWARDED ISO 13485


Metropolis Healthcare – thepathology specialists andmultinational chain of

diagnostic centres conducted acomprehensive analysis of over10,21,352 samples that wereprocessed for fasting blood sugarfor over the last three years.

The in-depth analysis revealed thatover 60% of all samples from maleand 51% of samples from femalewere diabetic. In addition, over 28%of the samples analysed fromchildren between the age group 0-12 was found to be diabetic.

Commenting on the study Dr. SonaliKolte, General Manager, MedicoMarketing said, “India is alreadyinfamous as the diabetic capital ofthe world and the incidence isincreasing due to various factors,such as unhealthy eating habits, lackof physical activity, family history andstress. Diabetes is a lifelongcondition and requires regularmonitoring. People with diabetes aresusceptible to kidney dysfunction,cardiovascular diseases, neurologi-cal problems and much more.Hence Diabetics need to undergoregular tests and monitoring to

ensure that all their vital parametersare normal’’

According to statistics fromInternational Diabetes Federation,India Chapter around 65.1 millionpeople are affected with diabetescompared to 50.8 million in 2010. Itis expected to reach around 69.9million by 2025.

There are three types of diabetes:1 Type 1 Diabetes - The body doesnot produce insulin. Approximately10% of all diabetes cases are type 1.A healthy eating plan, adequateexercise, and insulin intake can leada normal life.

2. Type 2 Diabetes -In type 2diabetes your body does not useinsulin properly. This is called insulinresistance. At first, your pancreasmakes extra insulin to make up for it.

But, over time it isn't able to keep upand can't make enough insulin tokeep your blood glucose at normallevels. Approximately 90% of allcases of diabetes worldwide are ofthis type. It often results from excessbody weight and physical inactivity.Healthy diet, regular physical activity,maintaining a normal body weightand avoiding tobacco use canprevent or delay the onset of type 2diabetes.

3. Gestational Diabetes - This typeaffects females duringpregnancy,usually around the 24thweek – many women developgestational diabetes. A diagnosis ofgestational diabetes doesn't meanthat you had diabetes before youconceived, or that you will havediabetes after giving birth. When youhave gestational diabetes, yourpancreas works overtime to

Sugar disease growing at alarmingrate in India51 % WOMEN & 60 % OF MEN IN THE AGE GROUP OF 20-80 YEARS ARE WORST AFFECTED

AGE GROUP / CATEGORY DIABETIC TOTAL SAMPLE SIZE PERCENTAGE

0-12 (Juvenile ) 1333 4810 28%Male (20 -80 & Above) 304736 506047 60%Female (20 -80 & Above) 262986 510495 51%


produce insulin, but the insulin doesnot lower your blood glucoselevels. Although insulin does notcross the placenta, glucose andother nutrients do.

So extra blood glucose goesthrough the placenta, giving thebaby high blood glucose levels. Thiscauses the baby's pancreas to makeextra insulin to get rid of the bloodglucose. Since the baby is gettingmore energy than it needs to growand develop, the extra energy isstored as fat. This can lead tomacrosomia, or a "fat" baby. Babieswith macrosomia face healthproblems of their own, includingdamage to their shoulders duringbirth.

With type 1 diabetes, the symptomsusually happen quickly, in a matter ofdays or a few weeks. They're muchmore severe, too. The mostcommon diabetes symptomsinclude frequent urination, intensethirst and hunger, weight gain,unusual weight loss, fatigue, cutsand bruises that do not heal malesexual dysfunction, numbness andtingling in hands and feet. It isadvisable to get your blood & urinechecks done immediately, if yousuffer from any of the abovesymptoms.

Treatment for all types of diabetes isavailable. Diabetes type 1 lasts alifetime, there is no known cure.Type 2 usually lasts a lifetime;however, some people havemanaged to get rid of theirsymptoms without medication,through a combination of exercise,diet and body weight control. Ifdiabetes is not adequately con-trolled the patient has a significantlyhigher risk of developing complica-tions related to cardiovasculardiseases, neurological problemsand many more.

Being overweight, physically inactiveand eating the wrong foods allcontribute to the risk of developingtype 2 diabetes. If you are over-weight or obese, you are at greaterrisk of developing type 2diabetes,alterations of hormonessuch as leptin, cortisol, adiponectininvolved in food intake can lead toobesity. It is important to check

these hormones if you are obese oroverweight. Obesity appears tospreading across India in part at leastas a result of processed Westernfood. India’s economic boom hasbeen accompanied by a meteoricincrease in the number of peoplewith diabetes.

Even if the prevalence of obesityremains stable until 2030, whichseems unlikely, it is anticipated thatthe number of people with diabeteswill more than double as a conse-quence of population aging andurbanization.

In association with increasingdiabetes prevalence, mortality willinevitably result in increasingproportions of deaths fromcardiovascular disease, as well asincreased prevalence and associ-ated consequences of othercomplications of diabetes. Aconcerted initiative is required toaddress the diabetes epidemic.

About MetropolisAt Metropolis, what we believe iswhat we say and what we say iswhat we do. Being empathetic toour customers and being commit-ted to their needs is in our DNA.Metropolis has grown to harness aculture that is open, synergistic,progressive and scientific in nature.We are the Pathology Specialistsdelivering over 30 million tests a year,catering to more than 20,000Laboratories, Hospitals, Nursinghomes and 2,00,000 doctors. With34 years of experience in deliveringaccurate reports, Metropolis hasearned the reputation of beingIndia's most respected and onlymultinational chain of diagnosticcentres with presence in UAE, SriLanka, South Africa, Kenya, Mauritiusand Ghana.

Driven to make a difference, ourwide network includes 130 state-of-art Laboratories with over 1000collection centres, processing over4500 varieties of tests and sup-ported by an efficient team of morethan 3500 people. Equipped withcutting edge technology, innovativework equipment, expansive logisticsnetwork and rigorous processes,Metropolis ensures and deliversprecision and accuracy in every

single test; each time, every time.

Over the past two decades,Metropolis has expanded into newservice lines like Clinical Trials,Hospital Lab Management, HomeHealth Services, Preventive HealthCheck-ups and Corporate &Wellness Solutions. Metropolis is atthe forefront in adopting cuttingedge technologies and services thatcontribute new revenue streams andhas positioned the company on thepedestal it is today.

Today, we are one of the fewlaboratories that has received theCAP (College of American Patholo-gists), accreditation, the global goldstandard in Laboratory Accreditation.We have also received the NABLAccreditation (National Accredita-tion Board for testing and CalibrationLaboratories). In addition, we alsoadhere to CLIA (Clinical LaboratoryImprovement Amendments)program and follow the guidelineslaid by GCLP. Our unit in South Africais accredited by SANAS (SouthAfrican National AccreditationSystem is the only accreditationbody approved by South AfricanGovernment).

At Metropolis, we believe inunveiling the inner health ofindividuals and this motto extendsto our corporate social responsibilityactivities as well. Giving back to thesociety is embedded in the valuesystem of Metropolis and webelieve and aim to bring about apositive change in the nation.Metropolis has been at the forefrontin conducting impactful camps anddriving numerous workshops fordifferent sections of the society forthe past 3 decades. We partner withsocieties, corporates, educationalinstitutions, government bodies,NGOs, wellness foundations and ahost of other organisations to makea difference to the lives we touch.Our camps and awarenessworkshops emphasize on preven-tive healthcare and early screening ofdiseases. Some of our most recentassociations include EpilepsyFoundation, Hep Free India, MumbaiTraffic Police, Kishori Foundation,Children of Blind School andJeevanJyot Cancer Trust.

Metropolis has been awardednumerous accolades like the ‘BestDiagnostic Company of the year’ byModern Medicare in 2006 and ‘BestDiagnostic Company of the Year’ in2010 by Frost & Sullivan. Metropoliswas also bestowed with ‘Best ITIntegration in Customer ServiceManagement’ at the e-Health WorldExpo 2011. Metropolis was alsohonoured with the ‘Quality BrandAward’ by NEHRDO in 2012.Metropolis won the ‘CMO AsiaAward’ for Best IT practices inHealthcare in 2012. Metropolisrecently bagged the ‘India’s mostpromising brand award’ at GlobalIndian Excellence Summit 2014 heldin London. Metropolis also won theacclaimed Emerging CompaniesExcellence Award hosted byBusiness Today in 2014. In 2015Metropolis won the Best DiagnosticCompany Award at the NationalAwards for Excellence in Healthcarehosted by CMO Asia.

Metropolis also won the BestDiagnostic Service Provider Awardhosted by VC Circle.Metropolis Healthcare is led byAmeera Shah, Promoter, ManagingDirector & CEO. An International &National award winner, Ms. Shahwas conferred with ‘The Youngentrepreneur of the Year Award’ byGE in 2006 and ‘The Young Achieverof the Year Award’ at the CMO AsiaAwards in 2011.

She was also the recipient of theprestigious ‘Young Entrepreneur ofthe Year Award’ in 2011 organizedby Entrepreneur India andBloomberg. She has been honoredwith ‘Exemplary Women Leadershipaward’ at the World WomenLeadership and Congress awards2014. She has been chosen as oneof the most respected leadersunder 40 years by Economic Times& Spencer Stuart (2014).Recently Forbes Asia listed Ms. Shahin the Asia’s Most Powerful Women2015 for powering the rise ofMetropolis Healthcare and brining asignificant shift in the diagnosticsindustry. Ms Shah has also beenfeatured in the acclaimed ‘YoungGlobal Leader’ list brought out bythe prestigious ‘World EconomicForum’ in 2015.


India's poultry industry is one ofthe largest in the world andemploys over 25 million people. It

contributes Rs. 95,000 crores to theeconomy each year with Telanganacontributing substantially to thefigure

Poultry India, an advisory body witha unanimous primary mandate ofspearheading the ‘Eat Right, EatHealthy’ educational campaign,today said its all-India ProteinAwareness Campaign has pickedsubstantial momentum following itslaunch in Pune last month withnutritionists and poultry farmers

assisting in propagating the messagethrough various mediums.

The national initiative to educatepeople on the vital role proteins playin enhancing day-to-day health,fitness and general wellbeingincludes an eclectic choice ofcommunication vehicles like road-shows, open house discussion withparents, teachers and schoolchildren in urban and semi-urbanareas, town-hall meets with villageelders and guardians, etc. PoultryIndia has also begun circulateprinted material to retail outletshighlighting the importance of

protein and what would be theconsequences for the lack of itsintake.

It is but natural that the state ofTelangana,which is among thecountry’s largest poultry producers,is the next stop on this campaign.Chief Minister K Chandrasekhar Raohas recognised poultry as a keysector and has extended help to itsfarmers through subsidies andincreased facilities.India is the thirdlargest egg producer in the worldafter China and USA and employsover 25 million people. It contrib-utes Rs. 95,000 crores to the

economy each year with Telanganacontributing substantially to thatfigure.

One out of every five eggsproduced in India is from Telanganaand Andhra Pradesh.Little wonderthen that the Government of Indiaclosely worked with Poultry Indiaand its associates to propagateWorld Egg Day on 9th October,2015 through several eventsincluding essay writing and eggrecipe/ cooking competitions forstudents, women, teachers, as alsocreated awareness on the impor-tance of eggs by distributing flyers

POULTRY INDIA’S PROTEIN AWARENESS CAMPAIGNREACHES TELANGANA; HIGHLIGHTS PROTEINDEFICIENCY IN THE COUNTRY

INDIA HOUSES 194.6 MILLION PROTEIN DEFICIENT AND UNDERNOURISHED PEOPLE - THE HIGHEST IN THE WORLD - AND WHERE MORE THAN 65MILLION CHILDREN UNDER THE AGE OF 5 ARE STUNTED

AN AVERAGE INDIAN CONSUMES APPROX 37 GMS/DAY, WHICH IS NEARLY HALF THE LEVELS RECOMMENDED BY WHO

A PERSON MUST CONSUME AT LEAST 1 GM OF PROTEIN PER KILOGRAM OF BODYWEIGHT PER DAY


and information brochures.

Commenting at the launch Mr. HarishGarware, Executive Committeemember, Poultry India, said, “Despiteimprovement in education levelsand poverty elevation Indiaunfortunately is still a malnourished,protein deficient nation and worldcapital of TB, diabetes and obesity.This is only because our foodculture has not yet evolved withtimes. We do not dispute theimportance of protein but none ofus are aware how much we needdaily and how to fulfill it. We needone gram of protein for everykilogram of our body weighteveryday because our body cannotstore protein. This is the messagePoultry India wants to take forwardthis in this Protein Awarenesscampaign for the benefit of all.Prosperity automatically brings inawareness and a shift in ournutritional culture. If you keenlyobserve, all prosperous countrieshave eventually shifted fromcarbohydrate-based to healthyprotein rich food culture.”

According to a definitive survey'Protein Consumption in the Diet ofadult Indians Survey' (PRODIGY)published in India highlighted thefact that 80% of all Indians areprotein deficient. The survey wasconducted in seven major Indiancities among 1,260 respondentsand concluded that and as many as91% vegetarians and 85% non-vegetarians are deficient in proteins..The epidemic of lifestyle diseases -obesity, diabetes hypertension, andhigh triglyceride levels - in urbanIndia can also be addressed ifIndians increase their dietary proteinintake, the survey said. (Ref: http://www.hindustantimes.com/wellness/80-of-indians-suffer-from-protein-deficiency/article1-1354357.aspx

Mr. OP Singh, Core CommitteeMember, Poultry India said,“Proteincannot be stored. Your body needsit daily. In right quantities.Today,Protein-Energy malnutrition (PEM) inyoung children is currently the mostimportant nutritional problem thathas reached near epidemic status.This often results from consumingfood that is low in protein. Throughour efforts we are aiming tosignificantly reduce our nation’smalnutrition and protein deficiencyquotient with cost effective andeconomical source of Proteinswhich, most importantly, is easilyavailable anywhere in any streetcorner outlet.”

International Diabetes Federation(IDF) official estimate of India’sdiabetic population was 65.1million. Indian media reportedaround 67 million diabetics in Indiain November 2013. That’s danger-ously close to IDF’s 2007 predictionof India’s diabetic population in2025 touching 69.9 million. It seemswe are reaching this unsavourymilestone 10 years too early!

By 2030, India will be home to 1.6billion people, which means overalldemand for food will be muchhigher. Furthermore, while there aremany poor in India (roughly 60% ofthe population), there are also somevery rich people, along with a rapidlyrising middle class population.Incomes have been rising by 7-8%.Hence there is greater demand notjust for more food, but also forbetter quality food.

Mr. Ranjith Reddy, Managing Directorof SR Hatcheries and head of PoultryBreeders Association of Telanganasaid, “The Protein AwarenessCampaign is a worthy project byPoultry India and we applaud itwholeheartedly. I also want to tell

you that our Chief Minister Mr. KChandrashekar Rao has takenmeasures to ease the burden on theState’s farmers with subsidies onfeeds and electricity as alsoaccrediting the poultry industry withan Agriculture Status. This is giving usconfidence that our government isbacking us in everything we do,especially in the Protein AwarenessCampaign The ‘Eat healthy, Eat Right’campaign is thus aimed at educatingpeople on the goodness ofproteins -- from any sourcevegetarian or non vegetarian and theimportant role proteins play insupporting day-to-day health,fitness and general wellbeing.”

“Our Honourable Prime MinisterNarendraModilauncheda worthycampaign Swacch Bharat-SwasstBharat to educate us on how to stayclean and thus stay healthy. PoultryIndia wants to support our PM byeducating people on eating right,eating healthy. We want to tell themthat obesity means various lifethreatening diseases and that itdecreases the quality of life andincreases individual and nationalhealthcare costs,” Mr. RanjithReddycontinued.

Another key highlight of thecampaign is highlighting the varioussources of proteins in easily availabledaily foods.

Dal and beans offer protein andtend to be sources of severalminerals like potassium andmagnesium. On the downside, theyoffer only a moderate, at best,amount of protein. Digesting dal andbeans is not easy, hence manyexperts recommend limiting itsintake quantity for up to 50-60 gramsper day.

However, this gives you only 10-11

grams of protein per day which ismuch less than the recommendeddaily protein intake of 1 gram ofprotein for every kilogram ofbodyweight everyday! So if youweigh 70kgs, you need 70gms ofproteins everyday!

Indian diets derive almost 60% oftheir protein from cereals withrelatively low digestibility and quality.There have been several surveys ofdiets and protein intakes in India bythe National Nutrition MonitoringBoard (NNMB) over the last 25 yearsin urban and rural, as well as in slumand tribal populations. Data ofdisadvantaged populations fromslums, tribals and sedentary ruralIndian populations show thatprotein intake (mainly from cereals)is about 1 gm/kg/day. However, theprotein intake looks less promisingin terms of the protein digestibilitycorrected amino acid score(PDCAAS), using lysine as the firstlimiting amino acid, where allpopulations, particularly rural andtribal, appear to have an inadequatequality to their protein intake. Thequality of egg and chicken protein iscomplete with all required aminoacids for effective utilisation by thebody with PDCAAS scores of 1.

If one were to get protein needsfrom dal alone you would have toconsume a huge amount of dal andbeans. (See below chart) Theycontain 25% protein and approx50% starch or high carbohydratecontent, which explains why they’reso hard to digest. Also, beans arerich in protein and starch (requiringdifferent digestive environments andenzymes) and this can makethorough digestion more difficult.While its protein is being digested,starch lies in the stomach andferments producing gas and toxinsmaking one feel bloated and


uneasy.Eggs contain decentamounts of vitamin A, D, E, K, B5,B6, B12, B2 calcium, phosphorus,folate, selenium and zinc. They arehighly fulfilling and tend to make eatfewer calories, helping in losingweight.

Dr Janaki Srinath, Nationally Ac-claimed Nutritionist from Hyderabadsaid: “Given the risk low proteinlevels pose to the health of Indians,spreading proteins evenly acrossmeals is extremely important.Combining vegetable, grain, pulses,egg and dairy products gives you aperfect protein intake for the day.

“Consumption of adequate proteinensures strong immune defense,efficient signaling of nerves andimpulses, healthy hair and mainte-

nance of fluid balance in the body.Protein can also turn into an energyprovider when required by thebody. Insufficiency of protein in thebody affects all organs and overallgrowth and development.

Probably the most importantcontribution of protein is its ability toreduce appetite and cause aspontaneous reduction in calorieintake. Protein intake is essential forstages of life leading to a betterbody composition and metabolicrate in modern sedentary lifestyles.Protein is much more satiating thanboth fat and carbs”, Dr Janakiadded.

Mr D Ram Reddy CMD, Sneha FarmsLtd said, “I am so glad the awarenessthrough Poultry India’s Protein

campaign is growing strong. We, thepoultry farmers of Telangana,appreciate this campaign and alsothank our state government for notonly supporting the campaign butalso thank our Chief Minister for hishelp to the poultry sector.”

WHAT IS PROTEIN

Proteins are a group of biologicalcompounds which are present inevery live cell, organ and tissue ofthe body. They are there in the formof enzymes, antibodies, hormonesand much more. Meaning ‘first’ or‘of prime importance’ in Greek,proteins participate in every cellularprocess occurring in the body.Proteins are responsible for theformation, regulation, repair andprotection of the body of eachorganism.

It executes a range of functionswithin living beings includingcatalysis of enzymes, DNAreplication communication andcoordination within the cells,molecular transportation from onelocation to another. There are 20amino acids considered essentialbecause the body must have all ofthem in right amounts to functionproperly.

Twelve of these proteins aremanufactured in the body but theother eight amino acids must be

provided by diet. Foods fromanimals sources such as milk or eggsoften contain all these essentialamino acids, while a variety of plantproducts must be taken together toprovide the body and the mind allthese necessary proteins. Goodhealthy sources of proteins are nothard to find for both vegetarians andnon-vegetarians. Meat eaters canchoose from eggs, chicken,cooked lean meat and fish.Vegetarians can choose from nuts,seeds, soy products like tofu, dairyproducts and legumes includingvariety of beans and split peas.Key facts (World HealthOrganisation)

Worldwide obesity has nearlydoubled since 1980

In 2008, more than 1.4 billionadults, 20 and older, were over-weight. Of these over 200 millionmen and nearly 300 million womenwere obese

35% of adults aged 20 and overwere overweight in 2008, and 11%were obese

65% of the world's populationlives in countries where overweightand obesity kills more people thanunderweight

More than 40 million childrenunder the age of 5 were overweight

BELOW IS A TABLE OF PROTEIN CONTENT FOR VARIOUS FOODS:

Item Weight in gms Protein per 100gms Commodity priceper 100gms (Rs approx.)

Egg 100 (2 eggs) 13.2 9Chicken 100 30 15Mutton 100 26 40Milk (FULL FAT) 100 3.2 5Yogurt 100 5 13Paneer (FULL FAT) 100 11 35Fish 100 22 30Urad Dal 100 24 16Moong Dal 100 24.5 16Tur Dal 100 22 16


or obese in 2012

Obesity is preventable

Overweight and obesity aredefined as abnormal or excessive fataccumulation that may impair health.Body mass index (BMI) is a simpleindex of weight-for-height that iscommonly used to classifyoverweight and obesity in adults. Itis defined as a person's weight inkilograms divided by the square ofhis height in meters (kg/m2)

Overweight and obesity areleading risks for global deaths.Around 3.4 million adults die eachyear as a result of being overweightor obese. In addition, 44% of thediabetes burden, 23% of the heartdisease burden and between 7%and 41% of certain cancer burdensare attributable to overweight andobesity

In 2012, more than 40 millionchildren under the age of 5 wereoverweight or obese. Once

considered a high-income countryproblem, overweight and obesityare now on the rise in low- andmiddle-income countries, particu-larly in urban settings. In developingcountries with emerging economies(classified by the World Bank aslower- and middle-incomecountries) the rate of increase ofchildhood overweight and obesityhas been more than 30% higherthan that of developed countriesOverweight and obesity are linkedto more deaths worldwide thanunderweight. For example, 65% ofthe world's population live incountries where overweight andobesity kill more people thanunderweight (this includes all high-income and most middle-incomecountries)

ABOUT POULTRY INDIA

Poultry India is an advisory body witha unanimous primary mandate ofspearheading the Eat Right, EatHealthy educational campaign toraise awareness on the scourge of

protein deficiency prevalent in thecountry. This campaign focuses onthe need for a balanced daily dietconsisting high proteins. Eat Right,Eat Healthy is just one of the manycampaigns initiated by Poultry India.It also organises the Poultry IndiaExpo, one of South Asia’s largest,which brings together globalexperts on bird flock nutrition,breeding, poultry equipment andanimal health. The exhibition – nowin its ninth year in 2015 - alsoprovides insights into latest trendsand best practices in poultry farmingand breeding. Exhibitors from allover the world showcase theirequipment, products and servicesto Indian and foreign visitors. A one-day technical seminar ‘KnowledgeDay’ is also organised in conjunctionwith the Poultry India exhibition. The2015 edition of Knowledge Day andPoultry India Expo will be held inHyderabad’s HITEX City fromNovember 24-27.

The advisory body comprises headsof national organisations including

Indian Poultry Equipment Manufac-turers' Association (IPEMA), NationalEgg Coordination Committee(NECC), CLFMA of India (Com-pound Feed ManufacturersAssociation), Poultry Federation ofIndia (PFI), All India Poultry BreedersAssociation (AIPBA), AndhraPradesh Poultry Federation (APPF),Telangana Poultry Federation (TPF),Poultry Breeders Association-Telangana (PBA-T), Poultry BreedersWelfare Association Maharashtra(PBWA-Mah), West Bengal PoultryFarmers Association (WBPFA), TamilNadu Broiler Co-ordinationCommittee (TMBCC), BroilerBreeders Association - North (BBA-N), Karnataka Poultry Farmers &Breeders Association (KPFBA),Indian Federation of Animal HealthCompanies (INFAH), Indian PoultryJournalist Association (IPJA) and AllOdisha Poultry Association (AOPA).

Please visithttp://www.poultryindia.co.in andhttp://www.poultryprotein.com formore information.


The 23-time WTA tournamentwinner’s international appeal todrive new marketing campaignfor the BETADINE® range ofproduct.

International tennis star CarolineWozniacki was unveiled today asthe newest Mundipharma brand

ambassador for BETADINE®, thetrusted name in homes andhospitals for antiseptic liquids,creams, sprays and ointments. Aformer women’s world number onefor a total of 67 weeks, Ms.Wozniacki will be the face of a newBETADINE® integrated marketingand communications campaign thatwill be launched in selectedemerging markets withinMundipharma’s network over thenext 12 months.

"As a world-class athlete who nevergives up and battles her waythrough the pain to victory on andoff the court, Caroline perfectlyembodies the BETADINE® vision ofprotecting people in the global fightagainst infection, while promotinghealing and wound care,” saidRaman Singh, President, Asia Pacific,Latin America, Middle East, andAfrica, Mundipharma. "This partner-ship is a continuation ofMundipharma’s commitmenttowards building greater awarenessaround the importance of protect-ing our health and preventinginfection in our daily lives.”

BETADINE® products have beenused and are trusted as an antisepticfor more than 50 years andconsistently demonstrate strongefficacy against high strain viruses.

Over the last 5 decades,BETADINE® formulations featuringpovidone iodine1,2,3, a broadspectrum antimicrobial, have shownto be rapidly effective across varioustough virus strains including thosecausing pandemic outbreaks1,3,4,5.

“Tennis is one of the most physicallydemanding professional sports witha long season on tour, which makesit critical for professional tennisplayers to have an effective dailyregime against infection and injuries,”said Ms Wozniacki. “BETADINE® hasbeen a trusted partner in mypersonal journey, and I can’t wait toshare how the products can helpprevent and protect againstinfection.” In commemoration oftheir new partnership, Mundipharmainvited Ms Wozniacki to help unveil anew tennis-related GUINNESS

WORLD RECORDS™ title at AsiaSquare, in the heart of Singapore’sbusiness district. 16,000 tennis ballsin different colours were connectedtogether to create the world’sLargest Tennis Ball Mosaic. The tennisballs were designed to form a giantimage of children at play, with eachtennis ball representing the life of achild under the age of five that canbe saved each day. This is the goalthat UNICEF, the United NationsChildren’s Fund, has been workingtirelessly to achieve.

Mr Singh also commented: “Thisnew world record is a symbol ofMundipharma’s commitment toimproving access to healthcare inour global communities and oursupport for UNICEF and itscommendable vision of promotingthe rights and well-being of everychild.”

TENNIS STAR CAROLINE WOZNIACKI AND MUNDIPHARMAANNOUNCE PARTNERSHIP IN GUINNESS WORLD RECORDSTM

SETTING STYLE


Oxford Gene Technology(OGT), The MolecularGenetics Company, has

entered into a deal with BaylorMiraca Genetics Laboratories(BMGL), licensing the use of OGT’sproprietary single nucleotidepolymorphism (SNP) array probetechnology. This novel technologyovercomes the limitations ofrestriction enzyme-based SNPprobe approaches previouslyemployed at BMGL for loss of

heterozygosity (LOH) detection,allowing accurate array-basedanalysis of low-input DNA samples.

Based in Texas (US), BMGL providesthe highest-quality genomic servicesacross the US and to over 16countries worldwide, and as part ofthis objective, utilise aCGH arrayscontaining both copy numbervariation (CNV) and SNP probes toidentify a broad range of geneticsyndromes. For BMGL, OGT’sintensity-based SNP probetechnology provides a superioralternative to restriction enzyme-based approaches, which areunable to accurately analyse smallamounts of DNA.

The probes designed by OGT targeteach SNP allele, with the intensityratio following hybridisation allowingreliable detection of LOH. To ensurerobust and high-resolution LOHanalysis, each probe set has

OGT licenses SNP probe technology toBaylor Miraca Genetics Laboratories

undergone extensive optimisationand validation.

Vice President of Operations atBMGL, Mr. Sean Kim, commented:“We are dedicated to the rapiddelivery of the most accurategenetic analyses. Through theapplication of OGT’s technology,we are now able to provide reliablearray-based analysis of both copynumber variation and loss ofheterozygosity for challengingsamples. We are now also lookingto other areas of genetic analysis,expanding the use of this technol-ogy toward our complete portfo-lio.”

OGT’s SNP probe technology is akey component of its extensiverange of aCGH arrays coveringmultiple application areas, includingcancer and constitutional research.

The latest product in developmentutilising this technology is theCytoSure Constitutional v3 +SNParray, which provides enhancedexon-level coverage of all develop-mental disorders.

As a fully comprehensive approachto its genetic analysis strategy, BMGLalso utilises OGT’s Cytocell FISHprobes, and following a significantand successful validationprogramme, plans to further extendthe use of these probes. Dr MikeEvans, CEO of OGT commented:“Through granting the licence, weare proud to be advancing thecapabilities of such a prominentorganisation as the BMGL with ourSNP array probe technology andCytocell FISH probes. This presentsjust the first step in an ongoingrelationship, and we look forward tocontinuing this close cooperation.”

Proprietarytechnologyallows superiorLOH detection inchallengingsamples


Merck, a leading scienceand technology company,today announced the

relaunch of its brand identity. Thefundamental revision of the visualappearance as well as the introduc-tion of a new logo reflect thetransformation into a global scienceand technology company. At thesame time, the brand architecture atbusiness level has been simplified.Outside the United States andCanada, the company will operateuniformly as Merck.

"Merck has fundamentally changedover the past ten years," empha-sized Karl-Ludwig Kley, Chairman ofthe Executive Board and CEO. "Wehave developed from a classicsupplier of pharmaceuticals andchemicals into a global technologycompany.

With our unique combination ofhighly specializedbiopharmaceutical, life science andmaterials businesses, we are in aposition today to offer solutions tosupport global megatrends such ashealth and digitization. Thecomplete overhaul of our brandidentity is to communicate this newdirection vis-à-vis our customers,partners and applicants. We want tobe recognizable and remain visibleas Merck worldwide so as tostrengthen our well-known brandname. For this we have deliberatelyrid ourselves of outdated featuresand will be focusing on a young andeye-catching image."

The investment in the Merck brand ispart of the "Fit for 2018" strategictransformation and growth program,which includes the focus oninnovative, technology-drivenbusinesses as well as the modern-ization and expansion of globalheadquarters in Darmstadt,Germany. This also involves a moreself-confident and at the same timeclearer tone of voice, reflectingMerck's character and linking itspride in a nearly 350-year-old culturewith scientific curiosity and apassion for research.

With the introduction of the newbrand design, the previouslyindependent divisional brandsMerck Serono and Merck Milliporewill be eliminated. In the future,Merck Serono will operate as thebiopharmaceutical business ofMerck, and Merck Millipore as thelife science business of Merck.

"Following the two major acquisi-tions, the Merck Serono and MerckMillipore brands helped us toposition the duality of existing andacquired businesses in themarketplace. We succeeded indoing so. That's why we arereturning to the brand that we havebeen known under for nearly 350years," Kley added. Product brandssuch as Erbitux or MilliQ will not beaffected by this change.

Merck holds the rights to the Merckname and brand globally. The onlyexceptions are the United States and

Canada. The company will thereforecontinue to operate in these twocountries as EMD Serono in thebiopharmaceutical business, as EMDPerformance Materials in the high-tech materials business, as well asEMD Millipore in the life sciencebusiness up until the plannedacquisition of Sigma-Aldrich hasbeen completed.

Merck's visual image is fundamentallynew. It is based on the concept of avibrant science and technologycompany, and is inspired by thecolorful and multifaceted shapesseen under a microscope. The newMerck design features expressivecolors and shapes with a scientificlook-and-feel. These are alsoreflected by the new companylogo. In comparison with the formerlogo, it makes a bold statement; itsdesign is less complex and can beused in different colors.

"A comprehensive external andinternal analysis showed that wemust emotionalize our brandappearance to a much greater extentin order to be perceived as a vibranttechnology company in the marketand by applicants," said WalterHuber, Head of Group Communica-tions.

In addition, the new corporatedesign is to create a strong visual linkto the Merck businesses in theUnited States and Canada. For thisreason, the company is alsointroducing a striking, multi-colored

Merck Brand RelaunchedFUNDAMENTALLY REVISED BRAND IDENTITY REFLECTS TRANSFORMATION INTO ASCIENCE AND TECHNOLOGY COMPANY

Merck Serono and Merck Millipore become Merck

"M" in addition to the Merck logo. Itis to indicate the membership ofbusinesses and products to theMerck Group, independent ofcompany names or regions.

In its brand repositioning efforts,Merck was supported byFutureBrand, a leading brand agencythat advises Bentley and Nespresso,among others, and also worked onthe 2012 Olympic Games inLondon.

About MerckMerck is a leading science andtechnology company in healthcare,life science and performancematerials. Around 40,000 employ-ees work to further developtechnologies that improve andenhance life – frombiopharmaceutical therapies to treatcancer or multiple sclerosis, cutting-edge systems for scientific researchand production, to liquid crystals forsmartphones and LCD televisions. In2014, Merck generated sales of •11.3 billion in 66 countries.

Founded in 1668, Merck is theworld's oldest pharmaceutical andchemical company. The foundingfamily remains the majority owner ofthe publicly listed corporate group.Merck, Darmstadt, Germany holdsthe global rights to the Merck nameand brand. The only exceptions arethe United States and Canada,where the company operates asEMD Serono, EMD Millipore andEMD Performance Materials.


Pan India study of 14,96,683samples reveals alarmingstatistics

Mumbai, 13th October, 2015:Metropolis Healthcare – a multina-tional chain of diagnostic centresconducted an inclusive study onVitamin D, Vitamin B12 and VitaminB9 (Folic Acid) to observe thedeficiency and sufficiency ofVitamins within the inhabitantsacross India. Metropolis conducteda comprehensive pan India study on14,96,683 samples over a period of3 years. The increasing trend ofVitamin deficiency is seen in all theage groups. Among the samplestested across 4 zones viz, North,South, East, West 75% of popula-tion has shown alarming levels ofdeficiency.

Commenting on the study Dr. SonaliKolte, General Manager, MedicoMarketing said, “Indians have alethargic attitude towards Vitamins.Vitamin deficiencies usually developslowly over several months to years.

Symptoms of Vitamin D deficiencyare usually vague muscle/joint pain,weakness, bone pain, tiredness,fatigue or even depression.Nowadays it is observed thatpeople who are deficient in VitaminD are more likely to have diabetes,regardless of how much they weigh.Early diagnosis and treatment canhelp control the symptoms andprevent health related problems.”

The Study

In an analysis of over 14, 96,683patients who underwent Vitamintests, the following trends emerged.• 81.28% of all samples tested weredeficient in Vitamin D• 21.02% of all samples tested weredeficient in Vitamin B12• 15.06% of all samples tested weredeficient in Vitamin B9

Vitamin D: It has been a generalbelief that vitamin D deficiency isuncommon in India because ofabundant sunshine. There is,

however, now increasing evidencethat this is not true. Vitamin Ddeficiency has reached epidemicproportions in India despite amplesunshine.Vitamin D is uniquebecause it is a vitamin synthesizedby the body and it functions as ahormone.

Vitamin D is important for overallgood health and strong and healthybones. It’s also an important factorin making sure your muscles, heart,lungs and brain work well and thatyour body can fight infection. Yourbody can make its own vitamin D

from sunlight. You can also getvitamin D from supplements and avery small amount comes from a fewfoods you eat. They are vital foreveryone and ensure that your bodyworks well and is able to fight illnessand heal well. Vitamin D managescalcium in your blood, bones andgut and helps cells all over yourbody to communicate properly.

Most common reason to havedeficient levels of vitamin D is due tolimited sunshine exposure.Studies suggest that vitaminsufficiency may even help ease

7 out of every 10 Indians are Vitamindeficient: Metropolis Study

Gender wise patterns emerged as belowZone Male Female Average

Vitamin D DeficiencyNorth Zone 81.41% 75.97% 78.69%East Zone 85.10% 83.23% 84.17%West Zone 82.06% 78.54% 80.30%South Zone 81.27% 82.67% 81.97%

Vitamin B12 DeficiencyNorth Zone 29.70% 23.53% 26.62%East Zone 22.94% 21.05% 22.00%West Zone 23.89% 15.43% 19.66%South Zone 23.74% 7.90% 15.82%

Vitamin B9 DeficiencyNorth Zone 15.53% 9.36% 12.45%East Zone 16.28% 13.23% 14.76%West Zone 17.51% 9.25% 13.38%South Zone 29.33% 10% 19.67%

AGE GROUP WISE DEFICIENCY OF VITAMIN D IN BELOW TABLE

Vitamin D 1 to 20 20 to 40 40 to 60 60 to 80 & AboveDeficiency 23376 96268 94926 240540Sufficiency 5399 19019 29321 74010Grand Total 28775 115287 124247 314550% of Deficiency 81.24 83.50 76.40 76.47


Cost-effective, ready-to-use kitenables appropriate testingstrategies for reliable diagnoses

Oxford Gene Technology(OGT), The MolecularGenetics Company, has

launched its CE-IVD labelled CytocellAquarius® P16/3c/7c/17c Probe Kit,a cost-effective, ready-to-usefluorescence in situ hybridisation(FISH) probe kit for non-invasivedetection of bladder cancer — forsale in Europe.

Bladder cancer is becomingincreasingly prevalent, and in 2012was reported as the 5th mostcommon cancer in Europe1. Whilecytology screening is commonplacefor diagnosing bladder cancer, arecent update to UK NICE guide-lines2 recommended the use ofFISH. FISH methods have beenshown to have the same specificityas cytology screening and greatersensitivity in detecting bladdercancer cells3-4.

FISH analysis for bladder cancer isalso particularly useful for monitoringtreatment outcome and can aid inreducing patient mortality bydetecting bladder cancer recurrenceup to six months earlier than othermethods5.

Carrying the CE mark for in vitrodiagnostic use within Europe, OGT’sproduct accurately detects in urinesamples the three most commonaneuploidies associated withbladder cancer (chromosomes 3, 7and 17). It also detects deletions ofthe 9p21.3 locus6 containing the

well-known tumour suppressorgene p16 (CDKN2A) — commonlydeleted in bladder cancer7-8.

The economical Cytocell AquariusP16/3c/7c/17c Probe Kit containsready-to-use reagents and has aneasy-to-use protocol, reducing thepotential for errors and increasingconvenience. Specific, clear, high-intensity signals with minimalbackground deliver quality,reproducible and easy-to-scoreresults ensuring clinicians can beconfident in reporting. Dr. LorenzaPecciarini, cytogeneticist at the Saint

OGT launches Cytocell FISH probe forbladder cancer

Raphael Hospital in Milan, who extensively tested the probe on a large seriesof samples, commented: “We found Cytocell’s bladder cancer probe kiteasy to use, with bright results that were simple to interpret.

It was straightforward to incorporate into our existing cytology workflow andwas highly reproducible. This product offers an accurate and cost-effectivetechnology for the diagnosis of bladder cancer.”

Martin Lawrie, Managing Director at Cytocell said: “The decision to expandOGT’s cancer portfolio and specifically Cytocell pathology probes,demonstrates OGT’s commitment to the fight against cancer. Supported byrecent guidelines, our new bladder cancer probe kit delivers a convenientmeans to confident diagnoses, backed by the great customer support thatOGT has become renowned for.”

For more information, please visit www.cytocell.co.uk.


First ever MEDICINE + SPORTSCONFERENCE ASIA to featuregreater focus on Southeast Asia,bringing together sportsmedicine experts, healthcareproviders, physicians, fitnesstrainers and industry players todiscuss innovations in sportsmedicine and pertinenthealthcare challenges in theregion

To be held on 1st Sep 2016during MEDICAL FAIR ASIA 2016 ata new venue, the Marina BaySands Singapore

The MEDICAL FAIR ASIA, SoutheastAsia’s most definitive event forthe medical and healthcare

industry, will host the first ever Asianedition of the MEDICINE + SPORTSCONFERENCE in 2016.

The inaugural MEDICINE + SPORTSCONFERENCE ASIA will be held on 1stSeptember 2016 during MEDICAL FAIRASIA 2016 at a new venue, the SandsExpo & Convention Center, Marina BaySands Singapore.

The conference is jointly organized byMesse Düsseldorf Asia and NavispaceAG, with the support from foundingcooperation partners namely; SportsMedical Association Singapore (SMAS),Exercise is Medicine Singapore (EiMS),FIMS (International Sports MedicineAssociation) and WT WearableTechnologies Group.

Founded in 2013 at the largestmedical trade show MEDICA, theinternationally established MEDICINE +SPORTS CONFERENCE has repetitivelyattracted great speakers and high-levelattendees from around the world. Theinaugural Asian edition will feature

eminent speakers on topics such asphysical activity as a key to diseaseprevention, defining health and fitnessguidelines, creating the right activityprograms for athletes and non-athletes,vital data and performance monitoring,digital systems in elite and recreationalsports as well as new digital solutionssuch as new activity trackers,monitoring devices and other healthgadgets.

The conference also aims to feature agreater focus on the pertinenthealthcare challenges in the SoutheastAsia region, using the opportunityprovided by MEDICAL FAIR ASIA, withrelevant industry participation andattendance of quality trade buyersand decision makers, to generate high-level exchanges and discussions.

The established MEDICINE + SPORTSCONFERENCE has been brought to Asiain view of the booming sportsmedicine market in this region.According to market research solutionReportLinker, the Asia Pacific sportsmedicine market is estimated to growat a compound annual growth rate(CAGR) of 6.96% and is expected toreach US$3.85 billion by the end of2019.

At the same time, with the rapideconomic development andincreasing adoption of modern lifestylehabits in Southeast Asia, rising non-communicable diseases like cardiovas-cular diseases, chronic respiratorydiseases, and diabetes have becomeone of the major healthcare challengesin the region.

According to the World HealthOrganization (WHO), 62% of all deathsin the region are due to non-communicable diseases and 48% ofaffected persons are aged below 70years.

Mr Gernot Ringling, Managing Director ofMesse Düsseldorf Asia, said: “Over theyears, we have seen sports medicineadvance by leaps and boundsworldwide, making it important forstakeholders and industry players in thisregion to remain at the forefront of the

latest innovations and to address themost prominent healthcare challenges. Iam very excited for Messe DüsseldorfAsia to partner with Navispace AG inbringing MEDICINE + SPORTSCONFERENCE to Asia for the first time.This will enhance the experience of allour delegates at MEDICAL FAIR ASIA2016 and add significant value to theevent. MEDICAL FAIR ASIA is proud tohost the inaugural Asian edition ofMEDICINE + SPORTS CONFERENCE.”

“It is most appropriate and timely thatwe base the Asian edition of MEDICINE+ SPORTS CONFERENCE at MEDICALFAIR ASIA, the hallmark event for Asia’smedical and healthcare sector,” saidDr Sonja Sulzmaier, Managing Partner ofNavispace AG. “Healthcare investmentand the emphasis on sports medicineare shifting towards Asia, particularly inthe Southeast Asia region.

It is imperative to facilitate the rightdialogue and networking platform todiscuss how technology and innovationin this sector can help address someof the region’s healthcare challenges.We are confident that this inauguralconference will deliver valuableopportunities for discussions anddevelopment of solutions to meet thechallenges of the fast changinghealthcare landscape in this region.”

MEDICAL FAIR ASIA 2016, organized byMesse Düsseldorf Asia, will be heldfrom 31 August to 2 September 2016at a new venue, the Sands Expo &Convention Center, Marina Bay SandsSingapore. As a testament to thesignificance of the event for themedical and healthcare industry, 1,000exhibitors from 45 countries, 20national pavilion and country groupsand 15,000 qualified trade buyers and

decision makers are expected toparticipate in this 11th edition.

The 3rd edition of MEDICAL MANUFAC-TURING ASIA in 2016 will also co-locate with MEDICAL FAIR ASIA 2016to offer synergistic opportunities forspecialists sourcing diversified solutionsfor the healthcare and medtechindustries. Focused on the medicaltechnology and medical manufacturingsector, MEDICAL MANUFACTURING ASIAis jointly organized by MesseDüsseldorf Asia and the SingaporePrecision Engineering & TechnologyAssociation (SPETA).

About MEDICAL FAIR ASIA 2016

Organized by Messe Düsseldorf Asia,MEDICAL FAIR ASIA is part of the”World of MEDICA” brand and hasestablished itself as the region’s leadinginternational exhibition on hospital,diagnostic, pharmaceutical, medical &rehabilitation equipment & supplies.Following its successful growth pathsince its inception in 1997, MEDICALFAIR ASIA acts as the gateway to Asiafor global industry players by providingthe perfect platform to showcase thelatest industry innovations, to networkand do business.

For more information, please contact:Maria Wesson / Liliane LyeTel: +65 6332 9652 /+65 6332 9624Email: [email protected] /[email protected]

Exhibitor contact:Daphne YeoTel: +65 6332 9682Email: [email protected]

Or visit www.medicalfair-asia.com

MEDICAL FAIR ASIA to host inaugural Asian edition ofMEDICINE + SPORTS CONFERENCE in 2016


About Messe Düsseldorf Asia

Messe Düsseldorf Asia is a subsidiary of Messe Düsseldorf in Germany, one ofthe world’s leading trade fair organisers, responsible for organising more than 20global No. 1 exhibitions in various industries including medicine and health,specifically MEDICA, COMPAMED and REHACARE INTERNATIONAL held inDüsseldorf, Germany. With extensive expertise in organising trade fairs inSoutheast Asia, Messe Düsseldorf Asia has developed a portfolio of numeroustrade fairs in the region since 1995.

For more information, please visit www.messe-duesseldorf.de/MDA

UBM will organize CPhI Istanbul 2016 at Istanbul Congress Center from 1st -3rd June 2016. CPhI Istanbul 2016 is the foremost business platform to access the growing Pharma markets both in Turkey and MENA and Central Asia & Caucasus Regions.

The Hosted Buyer Program will also be organised with Ministry Of Economy, Matchmaking Program, Conference Program during the CPhI Istanbul 2016.

Connect, network and interact with 200+ exhibitors from 26 countries, 4.000 attendees from 80+ countries at Eurasia’s dedicated pharma event!

Pavillions in CPhI Istanbul 2016 : China pavilion, Italian pavilion, India pavilion

CPhI Istanbul and co-located events ICSE, P-MEC, InnoPack is your ultimate one-stop-shop for regional pharma solutions.

Hosting exhibitors from ingredients, contract services and technology through to packaging and machinery.

CPhI Istanbul 2016 brings you the entire Pharmaceutical supply chain under one roof.

Why Istanbul?Istanbul’s strategic position makes this event the perfect place to meet with regional suppliers from Europe, Central Asia and the MENA region.The Turkish Government aims to make Turkey one of the world’s top ten

economies in health services by 2023 by increasing R&D expenditures to 3% of GDP and by increasing exports to USD 500 billion.

Key reasons to visit:• Getaccesstotheregionalpharmamarketsandmeetwithexhibitors from Turkey, the Balkans, Central Asia, Middle East and North Africa. • Guaranteedindustrynetworking-meetregionaldrugmanufacturers and suppliers of pharma ingredients, machinery, packaging solutions and contract services. • Getthelatestmarketinsightsandfindoutaboutthelatestofferings of exhibitors during the exhibitor showcases. • Tapintothestronggrowingregionalpharmamarketsandmeetleading companies from the Eurasian region, such as Deva, Nobel Ilac, Pharmactive and many more.

For more details, please visit: www.cphi-istanbul.com

CPhI Istanbul 2016, A Meeting Point for International Health and Pharma Industry

01-03 June 2016, Istanbul Congress Center, Istanbul TURKEY


MediAngels.com, reputed to be theworld’s first online hospital, wasawarded as "Best Online HealthcareProvider 2015" at Frost & Sullivan'sIndia Healthcare Excellence Awards.The award was given in keeping withMediAngel's commitment andcontribution to bringing a change inthe healthcare delivery system.

While receiving the award Dr.DebrajShome, Founder and CEOMediAngels.com said, “This is ahuge inflection point in India. Justlike Indians jumped to the mobile,because of a lack of enoughlandlines, an online hospital likeMediAngels.com will revolutionisethe healthcare delivery sector andmake India jump from physicalhospitals to online hospitals. This isthe only way for all of India to gettop quality healthcare - deliveredthrough the phone, via the internet."We wish to thank all our supportersfor their love and affection, as welook to galvanise healthcare in India.

MediAngels, a four-year-old start-up, provides services includingonline video consultation and onlinemedical records. Voted as the mostinnovative start-up in the entireAPAC region in 2012 by Intel, it isfunded by marquee investors whichinclude HDFC Holdings, VentureEast,

Government of India, Department ofScience and Technology.

Being a medical expertise company,Mediangels aims to match the bestdoctor to every disease. To set up atertiary hospital in every district in thecountry is a daunting task for thegovernment which would costabout $1 trillion. Hence, e-healthcare becomes the bestoption. The health professionals that

form the core team of Mediangels are in tune with the changing dynamics ofmedical practice worldwide and the modern-day consumer’s expectationsfrom healthcare.

About MediAngels.comMediAngels.com is the world’s first online hospital. With a network of over350 medical experts handpicked from across the world, MediAngels.comdelivers quality healthcare and second opinion at the click of a button. Theplatform offers patients access to qualified, trustworthy super-specialists forany ailment, anytime of the day in the comfort of home, securely.MediAngels.com constantly enriches patient’s experience as a healthcareconsumer by adopting new and innovative technologies.

MediAngels bags Healthcare Excellence Award


First Sensor extends its range ofoptical sensors with innovativesolid-state silicon photomulti-

pliers (SiPMs) for the detection ofultra-low light levels down to singlephotons. Compared to conven-tional photomultiplier tubes, SiPMsoffer significant advantages such aslow operating voltage, excellenttemperature stability, immunity tomagnetic fields and a much smallersize for easy system integration.

The detectors are optimized for nearultraviolet (Series SiPM-NUV) or red,green and blue (Series SiPM-RGB)light detection with peak sensitivitiesat 420 nm or 550 nm.

The silicon photomultipliers consistof a matrix of multiple avalanchephotodiode (APD) micro-cellsoperated above their breakdownvoltage (Geiger mode). NUV- andRGB-SiPMs from First Sensor featureextremely low temperaturecoefficients of the breakdownvoltage and gain, which allows forhighly accurate and stable measure-ments. Enhanced materials andsemiconductor technology enable

low-noise devices with reduceddark count rate, crosstalk and verylow afterpulsing probability typ. <4%. The precision SiPM detectors aredesigned to achieve very high gain(>106) and high photon detectionefficiencies.

The edgeless SiPM dies ensure highcell fill-factors and maximized activeareas in array arrangements. TheChip-Scale-Package (CSP) providesa cost-effective and RoHS compliantsolution suitable for reflowsoldering.

For custom specific applications FirstSensor develops and manufacturesarrays, modules and completesystems for OEM customersworldwide.

Important features of the SiPM-NUVand SiPM-RGB silicon photomultipli-ers:

Ultra-low light detection down tosingle photonsLow operating voltageHigh gain and low noiseImmunity to magnetic fields

Typical applications of siliconphotomultipliers from First Sensorinclude high energy physics,medical diagnostics, nuclearmedicine, homeland security andanalytical instruments.

Due to the immunity to externalmagnetic fields, SiPM detctors areideal for medical imaging applica-tions such as combined tomogra-phy systems using magneticresonance tomography (MRT) andpositron emission tomography (PET)or single photon emission com-puted tomography (SPECT).

Further product information:www.first-sensor.com/sipm

About First Sensor AG

First Sensor AG is one of the world'sleading suppliers in the field ofsensor systems. Our companydevelops and manufactures bothstandardized and tailor-made sensorsolutions for the detection of light,radiation, pressure, flow, level andacceleration for applications in theIndustrial, Medical and Mobility

Solid-state silicon photomultipliers offerperformance and application advantages

growth markets. The companyproduces in-house and along thevalue-added chain from componentto system level.

With over 800 employees, we arerepresented at six German locationsand also have development,production and sales sites in theUSA, Canada, China, the Nether-lands, Great Britain, France, Swedenand Denmark along with a world-wide partner network.

We guarantee our compliancethrough regular successful certifica-tions of the sites according to ISO/TS 16949, ISO 14001, EN ISO13485, EN 9100 and ISO 9001 -matching the respective businessfield.

First Sensor AG is listed in the PrimeStandard of the German stockexchange in Frankfurt.

For more details on First Sensor,please visit: www.first-sensor.com

First Sensor AGPeter-Behrens-Str. 1512459 BerlinGermanyT +49 30 6399 2399

Technical press contact:Doris TischerDirector Marketing CommunicationsE-mail: [email protected] +49 89 80083-48


Over the years, Frost & Sullivan’s Healthcare Practice has recognizeddistinguished companies and individuals for their significantachievements and seamless contribution to the country’s

healthcare industry. Continuing its efforts, Frost & Sullivan successfullyhosted the seventh edition of its India Healthcare Excellence Awards onOctober 9, 2015 at Hyatt Regency, Mumbai.

The awards banquet, attended by the prominent figures in the healthcareindustry celebrated the success of the winning enterprises. Awarded fortheir growth strategies, due diligence in development and innovation,showcasing best practices adoption and host of other critical factors, the 25award recipients at the 7th Annual Healthcare Excellence Awards repre-sented the best-in-class of the healthcare business.

On the occasion, Sandeep Sinha, Vice President, Healthcare Practice, SouthAsia and Middle East, Frost & Sullivan said, “The award recipients of thisyear’s Healthcare Excellence Awards represent a mix of establishedenterprises and innovative start-ups, who with their capability to revolution-ize the healthcare industry, are expected to bring in groundbreaking

innovations and novel practices in India’s healthcare system. Frost & Sullivanis proud to recognize their efforts and encourage them in their futureendeavor.”

This year, the awards were presented across four major award categories:Pharmaceuticals and Biotechnology, Healthcare Delivery Services, MedicalTechnologies, and Research-based Awards.

Following a rigorous process of selection, the awards jury comprising ofeminent industry experts, key opinion leaders, and visionary innovators, ratednominees across eight to 10 parameters, backed by the research data fromFrost & Sullivan and their market knowledge and domain expertise.

Besides these categories, there were two Special Awards conferred by Frost& Sullivan to exemplary individuals who have contributed significantly to thehealthcare industry for its advancement and furtherance.

Frost & Sullivan Recognizes Innovative Strategies and StellarPerformance at its 7th Annual India Healthcare ExcellenceAwards 2015


The Diatron Group, globalprovider of hematology andclinical chemistry analyzers, will

launch a new 5-part differentialveterinary hematology analyzer - theAbacus Vet5, in Dusseldorf at theforthcoming Medica show on the16-19 November. This will beintroduced on booth 3A 07alongside Diatron’s new 3-partdifferential human hematologyanalyzer, the Diatron Aquila, whichdelivers lower costs and widerrange of use, from small laboratoryto point-of-care environments.

The Abacus Vet5 analyzer has acompletely new look and isoperated via a large capacitive touchscreen, greatly enhancing userexperience. New features include:increased on-board data storagecapability of up to 5000 recordsincluding histograms; a newcomprehensive QC package; andmore data export/connectivityfunctionalities, providing improvedcommunication with laboratoryinformation systems (LIS).

The new analyzer uses well-provenDiatron Veterinary reagents whichenable a wide range of hematologi-cal parameters to be tested on abroad panel of animal species. Each

reagent pack for the new AbacusVet5 includes a special hardware keywhich transfers important productdata (e.g. lot number and expirydate) automatically to the analyzer,eliminating transcription errors whileprotecting the system from beingused with non-recommendedreagents.

New 3-part differential human

Diatron to launch new 5-part veterinaryhematology analyzer at Medica

hematology analyzer - Diatron AquilaAlso on booth 3A 07, the DiatronAquila, a new 3-part differentialhematology analyzer (60 test /hourthroughput) will be introduced tothe laboratory world for the firsttime.

This innovative analyzer has beenspecially designed to provideunique solutions to the many needs

“The Abacus Vet5provides excellentusability and LISintegration”

of the rapidly evolving worldwidehematology markets.Requiring minimal bench space, thissmall analyzer has low reagentconsumption (<10ml), needs onlya small sample size (10ul) and hasan on-board reagent pack**(sufficient for circa 200 measure-ments).

www.diatron.com


PointMan™ DNA enrichmenttechnology for highly sensitivedetection of genetic mutations

For high resolution image, pleasecontact [email protected]

Cardiff, UK – 15th October 2015 –EKF Diagnostics, the global in vitrodiagnostics company, announcesthat results from a study involvingEKF Molecular’s PointMan™ DNAenrichment technology have beenpublished in Clinical CancerResearch [1], a journal of theAmerican Association for CancerResearch which focusses oninnovative clinical cancer researchstudies.

The study comparing tumor biopsywith noninvasive blood-basedanalyses brings together expertsfrom four major US cancer centersinvolved in the ‘Stand Up to Cancer’program - Massachusetts GeneralHospital, Harvard Medical School,The University of Texas, and WeillCornell Medical, NY. PointMan DNAenrichment technology was usedwithin the study for the highlysensitive detection of geneticvariations in circulating tumor cells(CTCs) in blood samples from non-small cell lung cancer patients.

In September 2014, EKF announceda two year research collaborationwith Massachusetts General Hospitalto develop PointMan assays that caneffectively detect treatable cancermutations in blood samples. Thisstudy shows that, subject to furtherclinical validation, liquid biopsy(tumor typing using blood as thesample source) is a realisticdiagnostic opportunity withsignificant advantages over tissuebiopsy.

The study, entitled “Detection of

T790M, the acquired resistance EGFRmutation, by tumor biopsy versusnon-invasive blood-basedanalyses”, focused on identifying theepidermal growth factor receptor(EGFR) T790M mutation, which isassociated with resistance to certaincancer drug treatments, usingalternative methods to invasive tissuebiopsies. The study identified theT790M mutation from a standardlung biopsy and then comparedthese results with tests on bloodsamples containing CTCs orcirculating tumor DNA (ctDNA) fromthe patient’s cancer. The T790Mmutation from the CTC samples wasenriched using EKF MolecularDiagnostics’ PointMan EGFR T790MDNA enrichment kit to enhance thesensitivity of the test procedure

EKF’s PointMan™ used in successfulliquid biopsy researchCOMPARATIVE STUDY OF TUMOR BIOPSY V NONINVASIVE BLOOD-BASED ANALYSES PUBLISHED

allowing accurate genotyping to take place.

A successful outcome of this research would be key for those developingnovel EGFR inhibitors capable of overcoming T790M associated resistance,whereby clinicians will be able to use regular blood tests to monitorprogress rather than painful and intrusive lung biopsies.

Julian Baines, CEO of EKF Diagnostics said: “This is the first publishedscientific paper to feature PointMan and, importantly, the authors are primarilyfrom four US cancer centers that are instrumental in the ‘Stand Up to Cancer’program.

These results show that liquid biopsy is well on the way to becoming arealistic diagnostic alternative to tissue biopsy, particularly when severalsamples need to be taken during the treatment period. Importantly this studyshows that PointMan enrichment technology could become an essential partof routine blood tests for cancer diagnosis and treatment monitoring.”

The scientific paper can be viewed here:http://clincancerres.aacrjournals.org/content/early/2015/10/07/1078-0432.CCR-15-1031.abstract?sid=92fd4483-c733-4004-aaf5-4e8ff00eaabe


Arogya Finance, a socialhealthcare venture based inMumbai tied up with Dr.

Reddy’s Laboratories a multinationalpharmaceutical company forproviding medical loans fortreatment of Hepatitis C. ArogyaFinance will facilitate easy EquatedMonthly Installments to patients topay for the drug for Hepatitis C anda few other therapies provided byDr. Reddy’s Laboratories.

“According to World HealthOrganization over 12 million peoplein India suffer from chronic hepatitisC leading to unexpected healthcareexpense burden. Arogya Finance inassociation with Dr. Reddy’s hastaken an initiative to offer medicalloans at reasonable terms andmaking it available at the right time,right place and reaching out to thepatients in rural India.

We are providing a one-stopfinancial solution for people in needwhenever and wherever there is anunforeseen medical emergency.”said Mr. Jose Peter, Co-Founder andCEO of Arogya Finance.

Arogya Finance does not requirecollaterals or formal income proofwhich is mandatory in other forms offinance. Arogya Finance offers aloan and makes it easily available

within 24 hours. The company offersmedical loans to the traditionally un-bankable, using a psychometric testas an innovative risk assessment toolto enable evaluation of the credit riskprofile of people outside the formalbanking system. The borrowers canrepay the loans in EMIs of upto 36months and is calculated in a waythat it does not exceed 25% of thetotal family income.

Arogya Finance has been recog-nized as one of India’s most uniquesocial innovators by Innovations inHealthcare, an organization foundedby McKinsey, USAID and the WorldEconomic Forum and SocialEntrepreneurship Accelerator atDuke (SEAD).

With over 150 healthcare deliverypartners and presence in 10 states,Arogya is also implementing aunique concept of an Arogya Card,a pre-approved medical loan for theentire family, across the nation.

About Arogya Finance:(www.arogyafinance.com)Arogya Finance, co-founded by Mr.Jose Peter and Mr. Dheeraj Batra, is asocial healthcare venture, whichoffers medical loans to thetraditionally un-bankable, usinginnovative risk assessment tools thatallows them to finance people

Arogya Finance Join Hands with Dr. Reddy’sLaboratories to Provide Medical Loans for theFinancially WeakFacilitates medical loans for Resof, a drug for treatment of Hepatitis C virus (HCV)infection and a few other therapies.

outside the formal banking system.

The business model is structured in a way, that it directly pays the medicalbills of an individual to the hospital or the healthcare service provider. ArogyaFinance has partnered with hospitals and other healthcare providers toensure that people can access medical loans for themselves and theirfamilies. Patients borrow from and repay Arogya Finance directly leaving themfree to get treated wherever they choose to do so.

To ensure maximum reach, Arogya Finance has developed a path-breakingproprietary approach, which enables it to lend to even those who falloutside the formal sector. Arogya’s approach does not require collateral orincome proof. Arogya has developed a truly Indian approach to solving thehealthcare affordability issue in India.


BigChemist.com is an A3T Retails Pvt Ltd company founded in May 2013head quartered in Delhi. BigChemist.com is India's largest e-platformfor genuine Medicines and Healthcare products.

The aim behind BigChemist.com is to facilitate customers with genuinemedicinesand other healthcare products at affordable prices.

BigChemist.com aims to create awareness around availability ofsubstitutesthus enabling customer to take informed decisions at theconvenienceright in the privacy of their home and office.

The company was found on the grounds of giving simple, effectivesolutions to people in need of Medicines online in India. Big Chemist offersIndia's largest range of genuine Medicines, health products across categoriesand all major brands at one platform. BigChemist is run by a core team ofhighly qualified professionals with experience and strong skills in Healthcare,Pharmacy Benefits, Technology, Operations and Customer Management.

A team of trained nutritionists, counsellors and product experts helpcustomers in choosing the right product/service via email and phone. Big

Chemist has both online presence in www.bigchemist.com (having over 1.2lakh visitors) and physical brick & mortar storesincluding captive & localneighbourhood pharmacy partners in NCR region.

Big Chemist sources the best health & wellness products from across theglobe & provides them to every Indian via online shopping. The offeringcovers categories like Health &Nutrition, health instruments, Personal Care,Beauty, Parenting &evolving Healthcareservices. It partners directly with thebrands and their authorized channels, to ensure strict quality control anddeliver 100% genuine products.

BigChemist.com strives toexcel in its vision ofbecoming a dependable,household name in India,and offering customersdirect access to genuinehealthcare products at bestprices.

BigChemist.com is an initiative for creating an integrated online market placefor healthcare product & services across value chain with focus on servingB2C & B2B as Omni channel experience


Advanced Cell DiagnosticsInc. (ACD), a technologyand market leader in the

field of molecular pathology anddeveloper of cell and tissue-basedRNA analysis tools, is celebrating asignificant milestone. Over 300 peer-reviewed research papers have nowbeen published that feature ACD’sRNAscope technology as a corepart of the research methodology,reflecting its facility in advancing thelatest biological research in bothacademia and industry.

RNA in situ hybridization (ISH) is avaluable tool for studying spatial andcell-specific gene expression, whilepreserving tissue architecture. ACD’sRNAscope represents a break-through advance in RNA ISH,implementing a proprietary signalamplification system to enhanceboth sensitivity and specificity,producing a high-performance assaythat is also quick and easy to use.

As awareness has spread of howRNAscope ISH can accelerate avariety of studies, its rise in uptakehas translated to a rapid increase inpublished research. Thus far in 2015,the number of new publications hasalready exceeded 150, more thanthe total number of publicationsfrom all the previous years com-bined, signaling acceleration intechnology adoption. Chief

Scientific Officer, Dr. Xiao-Jun Ma,commented: “This rapid increase inpublications speaks directly to thevalue of RNAscope technology inmany fields of research. Spatiallymapped single-cell gene expressiondata are crucial to understanding thedevelopment, structure and functionof complex tissues at the molecularand cellular level.

However, obtaining such data hasbeen a huge bottleneck due totechnical difficulties of traditionalRNA ISH methods and the loss ofcontextual information with grind-and-bind assays.

With RNAscope, such data can begenerated within weeks from aconcept to publication qualityimages.”

The papers range from basicresearch in developmental biology,neuroscience, stem cells andophthalmology, to translationalresearch and diagnostic develop-ment of biomarkers in cancer andinfectious diseases, in respectedjournals such as Nature, Science,Cell, New England Journal ofMedicine, PNAS, PLoS One, andClinical Cancer Research.

Browse ACD’s publication databaseonline. For further information, youcan also visit www.acdbio.com

ACD’s RNAscope® Technology Achieves300-publication Milestone

“Use of next generation RNAIn Situ Hybridization across adiverse array of applications”


They are ideal, unique and healthy gifting options thisDiwali. In the current times when our loves are facingtroubles of blood pressure, sugar levels and stress,

there could be no better gift than energy jewellery thatbalances your magnetic field for stable blood flow andpeaceful state of mind.

Aarogyam Energy Watch by Aarogyam Energy Jewellery

Aarogyam Energy Watch helps to release tension frommuscles. The magnetic fields accelerate toxin flushout frombody and gently message the cells to release more endor-phins. Regular wear of magnets and lava stones also enhancesimmunity and improves the anti-infective activities of the body.This stylish and affordable Energy Watch comes with stainlesssteel casing and strap.

Aarogyam Biomagnetic TitaniumBracelet by Aarogyam EnergyJewellery

Aarogyam Biomagnetic TitaniumBracelet is made up of Titanium /Stainless Steel metal with pureNeodymium magnets (King ofMagnets) Neodymium is a Rare EarthMetal. It helps in regulating BloodCirculation which helpful to solvemany health problems related todiabetes, blood pressure problems,some of dangerous pains of ahuman body.

Aarogyam Quantum Science AMPendant by Aarogyam EnergyJewellery

The Aarogyam Quantum ScienceAM Pendant is based around thesame zero point energy concept asthe M wand. The Aarogyam EnergyAM pendant is designed andcreated using certain advancedminerals that is held in a titaniumcase, fusion and processed byAMized Fusion Technology.

Aarogyam Energy Jewellery brings to youideal, unique and healthy gifting options

The Aarogyam Quantum ScienceAM Pendant itself is designed toresonate at zero point energy andhelp the human bodies’ bio energyfield restore itself to its naturalhomeostasis condition.Wearing Aarogyam AM energypendant will help to increase thebody’s ability to fight stress that maycome from everyday life and alsohelp to combat the effects that cancome from living in a e-smogenvironment.

Available on: www.unltdoffers.com


Advanced Cell DiagnosticsInc. (ACD), a technologyand market leader in the

field of molecular pathology anddeveloper of cell and tissue-basedRNA analysis tools, has announcedthe launch of its new website,www.acdbio.com. In response tothe growing popularity of ACD’sproprietary RNAscope® in situhybridization (ISH) technology, thesite has been completely re-designed to better serve itsthousands of monthly visitors.

The new site graphically presentsRNAscope technology, with

streamlined navigation to interactivelypresent all resources. New visitorscan now rapidly and visually learnabout the technology, see itsapplications and access relevantpeer-reviewed publications. Withfast and convenient e-commercecapabilities, ACD’s customers willalso be able to access sales quotesin real time and place online orders,significantly easing the buyingprocess.

In light of its ability to sensitively andspecifically detect and quantify RNAtargets in the context of the cell ortissue, RNAscope ISH is becomingan increasingly popular technology,with over 300 peer-reviewedpublications to date featuringRNAscope ISH – currently at the rateof over 17 new publications permonth.

The new website reflects thisbusiness growth, together with the

Advanced CellDiagnosticsLaunches NewWebsite andOnline Store

company’s continual dedication tocustomer service. Tom Olenic, ChiefCommercial Officer of ACD,commented: “Of our monthly webvisits, the majority are from scientistswho are new to our technology,searching for how RNA ISH canenrich their research, so weprioritized visual presentation of ourtechnology and diverse applicationcontent.

On the other side, the sharp growthof our install base requires that weadopt modern B2B infrastructure toscale and ease the transactionalprocesses. Scientists are busy; sosearching through our 7,000 geneprobe catalog, which grew by over150% this past year, and selectingjust the right probe for the right genehas to be fast and easy.”

ACD will continue to expand itsonline store features, soon tosupport customers outside of theUS and also those who place ordersusing purchase orders. The newwebsite is one facet of ACD’sinitiative to incorporate modernbusiness infrastructure to supportand intimately interact with itsgrowing customer base.

For more information, you can seethe new website at

“Better serving the scientificcommunity, the new site isequipped with a fresh designand interactivity, and featurese-commerce capabilities”

www.acdbio.com.About Advanced Cell Diagnostics

Advanced Cell Diagnostics, Inc.(ACD) is a leader in the field ofmolecular pathology, developingcell and tissue-based diagnostictests for personalized medicine. Thecompany’s products and servicesare based on its proprietaryRNAscope® technology, the firstautomated multiplex chromogenicand fluorescent in situ hybridizationplatform capable of detecting andquantifying RNA biomarkers in situ atsingle-molecule sensitivity.

RNAscope assays are currently usedby thousands of customers,including all of the global top 10pharmaceutical companies, worldleading academic institutions andmany cutting edge biotechnologycompanies to validate biomarkersfor the management of cancer andother diseases. ACD’s industrialpartnerships provide the foundationfor ACD to develop companiondiagnostic tests in conjunction withpartners’ targeted therapeutics. ACDalso pursues internal programs todevelop and commercializeproprietary diagnostic tests in cancermanagement. Learn more aboutACD and RNAscope technology atwww.acdbio.com


STARLED3 NX grants a homogeneous and shadowless light thanks to its special LED optics created by ACEM Medical Company that directs light beams at best according to the needs. The visual area is perfectly illuminated assuring both excellent visual comfort and working conditions. Its next generation LEDs produce an unparalleled quality of light with a colour temperature (CCT) of

4.500 °K and a colour rendering index (CRI) of 95.

STARLED3 NX has a light intensity of 130.000 lux with a low energy consumption of 69W. The life cycle of its LEDs is about 50.000 hours.

STARLED3 NX is composed by three reflectors that produce a well-blended and intense cone of light focusable through the automatic adjustment of the light spot diameter. Its slim, practical and compact design makes it perfect for several uses. The lamp is ergonomic, easy to move and to position and suitable for the laminar flows of the operating room.

Its ENDO function (light for endoscopy) gives the possibility to use STARLED3 NX for minimal- invasive surgery too. The easy -to-clean shape and material of STARLED3 NX as well as its removable, sterilizable and easy-to-grip handle assure an excellent cleanliness.

Functions are adjusted by its innovative easy-to-read, ergonomic and easy-to-clean I-SENSE® control panel. With a simple touch it can manage easily and accurately:

• ON/OFF function

• Light intensity adjustment• DoF - Depth of Field - for a deep light• ENDO - Light for endoscopy ideal for

minimal-invasive surgery• SIZE - Light spot diameter

adjustment to focus the operating area• SYNC - Function (optional) useful to

synchronize controls of the combined lamps: STARLED3 NX double (twin dome configuration) and STARLED3 NX together with STARLED3 NX or STARLED7 NX.

STARLED3 NX is available in the following versions:Ceiling mounted, (Single, double configuration or together with other STARLED NX lamps) , Wall mounted, Trolley mounted ( ABPS battery on demand) .

ABPS is a rechargeable battery powered system made by ACEM Medical Company dedicated to power surgical lamps as by European Directive 93/42/EEC.

STARLED3 NX with ABPS has the same performance and appearance, since the structure containing the battery is within the trolley base. The structure which covers and protects the battery is made of resistant plastic, and its dimensions are: 550 x 340 x 240 mm. The control panel on the structure allows managing all fundamental parameters, such as residual charge, type of power supply, recharge status and electrical power supply presence, amongst others.

ABPS:• has an electronic control which allows for automatic switch from electric power supply to battery power supply so that STARLED3 NX can be used as a high performance mobile unit.

• is recharged by an automatic charger and requires no specific maintenance. Its autonomy may vary depending on the battery model, which can be from 12 Ah to 28

Ah with maximum charging time of about 8 hours.

For more information, please write to: Acem Medical Company Via della Tecnica 29, 40050 Argelato - Bologna – ITALY Phone + 39 051 721844, [email protected], www.acem.it

STARLED3 NX Surgical led lampSTARLED3 NX is a lamp manufactured by ACEM based on the Next generation LED technology, assuring cold light, long life and low energy consumption. The lamp is suitable for countless applications both for surgery and operating room. It is ideal for diagnosis, dental sector, gynecology, dermatology, general medicine and surgery.

4 | July-August 2015 | Medical Device ASIA Medical Device ASIA 20 | November-December 2015 | 47

MEDICAL JAPAN (February 24 [Wed] – 26 [Fri], 2016, INTEX Osaka, Japan) is the Japan’s first-

ever B to B trade show which covers all the products/services/technologies for healthcare

(medical devices, hospital supplies), clinical testing, diagnostics and medicines. The previous

show hosted 723 exhibitors from 20 countries/regions and attracted 27,692 professionals

worldwide, while in 2016, consisted of 6 specialised concurrent shows, it is expected to grow

to 1030 exhibitors from 25 countries and 38,000 visitors. Obviously, MEDICAL JAPAN makes a

precious meeting spot between top-notch professionals and aspiring companies worldwide to

generate a new trend of Healthcare and Medical industry.

One of the highlights is various conference sessions presented by leading

renowned experts. They will share new technologies, market trends,

unique business strategies and key to success in their innovative research

and development. 250 sessions will be held in appealing and plugged-

in lineup – especially one of the Keynote Sessions “The Future Vision of

Healthcare in Japan” will be presented by Mr. Shinsuke Kameda, director

of Kameda Medical Center, which is Japan’s largest private hospital

(excluding university hospitals) and ranked as No.1 in ability of medical

care system (according to survey by The Nikkei newspaper in 2013).

Kansai, where MEDICAL JAPAN is held, is home to world-class medical

research establishments. To make the most of visit, or experience the

assets of the area, MEDICAL JAPAN offers exclusive tours to visit some

world-class research institutions, such as Center for iPS Cell Research and

Application CiRA Kyoto University, directed by Professor Shinya Yamanaka,

2012 Novel Prize laureate and known as Mecca for iPS cell researchers.

The tours must be a not-to-be-missed opportunity to sneak secret to stay

on the front line in the ever-changing industry.

Now, register yourself for FREE invitation tickets at www.medical-jpn.jp/en/in and receive the latest information from Show Management.

To get exhibiting information, please access to www.medical-jpn.jp/en/ex/

or send inquiry e-mails to Show Management at visitor-eng.mj@reedexpo.

co.jp

MEDICAL JAPAN is the best gateway to grabbing the medical industry’s trend and expanding your business in Japan and Asia.

MEDICAL JAPAN 2016 - 2nd International Medical Expo & ConferenceSupported by Union of Kansai GovernmentsOrganised by Reed Exhibitions Japan Ltd. Venue: INTEX Osaka, JapanDate: February 24 [Wed] – 26 [Fri], 2016URL: www.medical-jpn.jp/en/E-mail: [email protected]: +81-3-3349-8519

Concurrent shows: - 2nd [Hospital + Innovation] Expo Japan- 1st Medical IT Solutions Expo- Nursing Expo Japan 2016 - 2nd International Nursing & Nursing Care Expo- MEDIX OSAKA 2016 - 6th Medical Device Development Expo Osaka- 2nd Regenerative Medicine Expo & Conference Japan- INTERPHEX OSAKA 2016 - 2nd Int’l Pharmaceutical R&D and Manufacturing Expo Osaka


In parallel to MEDICA, the world’slargest trade fair for medicaltechnology, the International

Conference on Disaster and MilitaryMedicine (DiMiMED) will be held forthe third time. This year, the maintopic of is operations in crisis areas.In view of the increasing need forhumanitarian aid in disaster zones,there is an additional focus oncivilian aid organizations and theirwork. Apart from plenary lectureson innovations and scientificquestions in disaster and militarymedicine, there is an interactivesimulation workshop dealing withthe practical implementation of aid inmajor catastrophic events.

Additional topics of interest includea session on disaster medicine ininternational comparison as well as agroup of presentations for industryrepresentatives on aspects of theprocurement of medical technologyby the German Federal ArmedForces and NATO. DiMiMED is heldunder the patronage of the MEDICALCORPS INTERNATIONAL FORUM(MCIF) and is organized jointly byBeta Verlag and Messe Düsseldorf.Around 50 international speakersand 200 participants are expectedto attend on 17th and 18thNovember at CCD Süd. MCIF is theonly independent magazine aimed

at medial services around the world.An editorial office consisting of top-quality professionals offers currentarticles of international importancefrom practitioners for practitioners,aimed at professionals in militarymedicine from more than 180countries.

No matter if we are dealing withmilitary conflicts, terrorist attacks,natural disasters or outbreaks ofdisease, the world-wide increase ofcrisis zones needs a sustained long-term management of medicalservices. In this connection, militarymedicine offers a broad coverage ofmedical care. “This year, we have puta strong focus on disaster medicine,since many military medical servicesworld-wide find that this isincreasingly developing into a largepart of their work, or at least thatthey have to work in disastermedicine as well as in militaryoperations”, said Rear Admiral uhMC (ret) Christoph Büttner, MD,scientific head of DiMiMED.

Within two days, the 200 expertsfrom medicine, industry and logisticswill be offered a broad spectrum ofinformation presented anddiscussed by about 50 internation-ally respected speakers in plenarylectures and, for the first time, also in

more depth in parallel sessions.Looking back, the second scientifichead Brigadier General (ret) Rob vander Meer, MD, says: “I co-chairedthe DiMiMED 2014 and saw a fruitfulexchange of information andexperiences. A shift of interest wasevident from operational medicalexperiences in Asia to Africa. Thedevelopment of new techniquesand future application in the forceswas important, both in very simplemethods as well as sophisticatedprocedures and also evaluationprocesses.” So indeed, a furtherdevelopment of the concept with amore focused approach has alreadybeen initiated.

Simulation workshop raisesawareness for a major catastrophicevent in Dusseldorf

A special highlight will be thesimulation workshop with a scenarioof a major catastrophic event. “Thissimulation was quite consciously‘placed’ in Dusseldorf, since anevent like the Boston assassinationcan happen anytime and in any city.For the simulation, we have thereforeinvited, apart from the militaryguests, high-ranked responsible stafffrom the ministries of the interior andthe police headquarters.

My goal is to motivate this targetgroup to conduct similar trainingscenarios in their area of responsibil-ity – which sometimes is actuallydone already”, explains Dr. Büttner,thus also referring to the co-operation with CAE Healthcare whoare, among others, offering themedical simulation technology.

Refugee crisis highlights urgentmedical problems

The session on “Disaster Medicine &Crisis Prevention” will be chaired byProf. Leo Latasch, MD, President of

the Deutsche Gesellschaft fürKatastrophenmedizin (DGKM,German Society of DisasterMedicine). He gives his opinion onthe most urgent issues that need tobe broached, both nationally andinternationally.

“Medical care for the huge numberof refugees world-wide, thequestion of a joint (!) approach toepidemics and outbreaks ofdisease, as well as the tasks of themilitary in a national context forissues like care for refugees andnatural disasters, taking into accountthe question why, if at all, are wealways asked so late?”

Making procurement processesmore transparent to the industry

Last not least: the workshop “MilitaryProcurement for Industry Partners“will explain procurement processesin military medicine on the exampleof the German Federal Armed Forcesand NATO. The session is especiallyintended to address industryrepresentatives who want to offertheir product portfolio for specialmilitary requirements in the homecountry and in the country ofoperation.

“Basically, we are interested in nearlyall areas of medical care andindications. Of course, some fieldslike paediatrics or geriatrics are notthat much in demand, except in rarecases of humanitarian aid afterearthquakes or after the tsunami inSouth East Asia. Emergency andrescue medicine are of coursealways extremely important –especially under the challengingconditions we meet in ouroperations abroad” explains ColonelPharmacist Dr. Ullrich Kindling, Headof Branch U3.5, The Federal Office ofBundeswehr Equipment, InformationTechnology and In-Service Support..

INTERNATIONAL DIMIMED CONFERENCE ON THE OCCASION OF MEDICA CONFRONTS CURRENTQUESTIONS ON THE CO-OPERATION OF CIVILIAN AND MILITARY MEDICAL FACILITIES

Efficient concentration of competencies indisaster medicine and military medicine


Kamani Oil Industries Pvt. Ltd.announced that they havebecome the first Indian

vegetable oil industry to get a FDAdrug license for manufacture ofPharmaceutical grade oils and fats(IP/BP/USP/NF)

The initiation of the facility wascarried out at Kamani’s Khopoli planton September 01, 2015.

Prakash Chawla, Director, Kamani OilIndustries said, “This is a greatachievement and moment of pridefor us to be honoured with thelicense. This gives us impetus tostrive for over exceeding thecustomer expectations who arereally special to us.

Kamani has been an organisation ofmany firsts and this certainly isanother feather in our cap. Thiscertification will assure our custom-ers about the integrity of ourmanufacturing process as well asour compliance with the stringentFDA regulations. ”.

The chief guest on this auspiciousoccasion was Mr. Pandita Maharaj –Regional Director Technical Opera-tions, Abbott Health Care Ltd. Someof the other distinguished dignitariespresent on this occasion wereAssistant Commissioner FDA, PEN(Maharashtra), and other guests fromInstitute of Chemical Technology,Mumbai, Cipla, Abbott Health CareLtd., Piramal Healthcare, FermentaBiotech, Herbinn Micro Medicines.

Speaking on this event, Mr. PanditaMaharaj said, “This is a big step forthe industry as a whole. Kamani hasbeen the first in the industry to bebestowed with this honour and this

certainly speaks volumes about theirstringent processes, reliability andcommitment to quality, health andservice. This definitely is a landmarkin their efforts to supply qualityingredients of global standards toPharmaceutical and Food Industryand raising the bar.

The whole pharmaceutical industry isgoing to get benefited from thisendeavour and will be assured ofinternational quality ingredientsindigenously and reducing theirdependence on imports.

Kamani Oils has made a significantmark in the pharmaceutical andculinary industry over the last 51years and has now been acknowl-edged and awarded with its duesby means of the FDA license. KamaniOils was also the first to become aHACCP, ISO 22000 – now FSSC22000 certified vegetable oilrefinery.

It was the first to procure, manufac-ture and supply sustainable palm oil,trans free oils and confectionery fats.The manufacturing facility at Khopolinow meets the requirements ofSchedule M of the Drugs andCosmetics act of 1940.

About Kamani Oils

Kamani Oils is a leading producer ofspecialty oils and fats started in1962. On offer are a wide range ofproducts for specialized applica-tions for the food industry as well asfor consumers. Besides specialityproducts for pharma use, theirproducts include a range of culinaryoils, inclusive of speciality fats forBakery, Confectionary & FrozenDessert.

PHARMACEUTICALS, NUTRITIONAND COSMETICS

SPECIALTY OILS FORPHARMACEUTICALSWe offer a range of specialty oils conforming to IP/BP/USP forpharmaceutical application. They are used as:

Carrier system for capsules, soft and hard gelsSolvent for oil soluble vitamins, hormones, in injectionsSolvent for oral suspensionsVehicle for topical preparations like ointments, balmsNovel drug delivery systemVeterinary vaccine formulations

We have introduced a range of exotic vegetable butters which canreplace Cocoa butter, Lanolin, some of the animal origin waxes,petroleum based products. They are ideal for:

Functional excipientsSuppositories and pessariesTablet coatingLubricant in directly compressible tabletsLipid based drug delivery systemsDermatological preparations- ointment, balm, creams

"BETTER SKIN CARE WITH KOSMECARE"

After extensive R&D studies, we have recently launched Kosmecare,which is a range of exotic butters and specialty-refined oils to caterto the requirement of various personal care products.

The exotic butters are of 100% vegetable origin and are useful forthe development of more nature friendly products. These ingredi-ents can replace Cocoa butter, Lanolin, some of the animal originwaxes, petroleum based products, etc that are used in differentcosmetic product formulations.

Unlike petroleum-based products, they are biodegradable too.These natural vegetable butters are economical quality substitutes forcostlier imported material and are most suitable for cost-effectiveelegant cosmetic products. These find application in developmentof a whole range of colour cosmetics (Lipsticks, Lip salves, Lip balm,Eye makeup products like Mascara, eye liners kajal sticks etc), Bodycare, Skin care, Hair care products and Cosmeceuticals.

CUSTOM MADE PRODUCTS

There are customers who require a very specific functionality in theoil / fat. We are able to tailor make products for these specificrequirements.

Kamani Oils receives FDA License


PITTMAN® Motors, a businessunit of AMETEK PrecisionMotion Control, is introducing

its latest offering: the BGE Series ofServo Motor Controllers, a family ofcompact 4-quadrant positioningmotion controllers with integraloutput stage to control Pittmanbrushless and brushed DC motors.

The motion controllers can beoperated in stand-alone operationwith digital or analog IO or as a slavein a CANopen network with deviceprofile DSP 402, protocol DS 301.The family of motion controllers israted from 12VDC to 60VDC inputvoltage and 4 amp to 20 ampcontinuous output current.

The BGE Series controllers aresuitable for use with Pittmanbrushless or brushed DC motors.Information about the motor’s rotorposition can be supplied to thepositioning controller by anencoder or integrated Hall sensorscontained within a brushless motor.

The controls incorporate protectionagainst over-voltage, low voltageand excessive temperature.

for restricted space applications where the additional length of an integralcontrol motor may not be feasible. They also can be encapsulated toprovide additional protection in extreme environmental conditions.

If only speed control is required for an application, the BGE 3004A, a cost-optimized 1 quadrant controller, is available. BGE controllers are availablefrom stock at the Pittman Express E-Commerce store. For a full listing ofavailable products with associated drawings, specifications and manuals,users can go to www.PittmanExpress.com .For more information, visit www.Pittman-Motors.com or contact an applica-tion engineer at 267-933-2105.

PITTMAN® Introduces BGE Series ServoMotor Controllers

About Pittman

Pittman is part of the AMETEK Precision Motion Control division. Pittmanproducts are designed into a wide variety of high-tech motion applications,including lab automation, medical devices, communications equipment,semiconductor processing equipment, aerospace systems, and many otherapplications where precision motion is critical.

The Pittman motor line spans a wide variety of DC motor sizes andtechnologies, ranging from 10 mm-diameter brushless DC motors used inhigh-speed medical applications to large NEMA frame DC servo motorsused in sophisticated automation equipment. Pittman also offers a widevariety of complementary products such as gearboxes, encoders, brakes,and drive systems. For more information, visit www.Pittman-Motors.com.

AMETEK Precision Motion Control is a division of AMETEK, Inc., a leadingglobal manufacturer of electronic instruments and electromechanicaldevices.

If 4-quadrant digital speed control isdesired, the control can becommanded to run in eitherdirection, stop and hold withtorque, and stop without torque(coast) through digital inputs. Otherinputs can switch betweenprogrammed speeds or allow for avariable analog speed reference.

Accel/decal ramps for the motoralso can be programmed. Thecontrol offers the capability for amotor to function as a stand-aloneor programmed servo, whichinterfaces to the rest of the machinevia digital and analog IO.

The BGE Series electronic controllersoffer many different modes ofoperation to choose from, such asanalog or digital torque control,analog or digital speed control anddigitally selectable position control(relative, absolute, and modulo).The controls incorporate protectionagainst over-voltage, low voltageand excessive temperature.

Designed for volume OEMapplications, BGE Series electroniccontrollers offer a design alternative


Always know your hand sanitizer! Most conventional hand sanitizersare alcohol based and stop working the moment you touchsomething.

But here’s an interesting revelation. Recently launched Klenza, is one of itskind foam based, alcohol free hand sanitizer with a Pure Silver basedformulation that is tested as per international standards. Made using a patentpending silver based technology, Klenza actively shields your hands with99.999% protection against germs. What is more, the natural goodness ofthe Pure Silver formulation provides continued three hour protection, thusensuring lasting resistance from germs.

Being an alcohol free sanitizer, Klenza is a non-toxic and non-flammablegreen product that doesn’t use any harmful ingredients like triclosan orparaben etc. Formulated using natural ingredients, this sanitizer can be usedat all times without any harmful side effects.

Exceptionally gentle and safe on all skin types including kids (3+ years).Unlike conventional alcohol based sanitizers, Klenza does not dry out theskin but instead keeps hands moisturized. Its distinctive foam dispenserpumps small quantities for easier and smoother application.

Klenza sanitizers are much safer and ensure 3 hour continued germprotection, making Klenza the best of its kind hand sanitizer.

Available in two exquisite fragrances Cool Cologne and Smooth Strawberry,Klenza comes in the 200ml foam pump for Rs. 198 with 250 applicationsand the 50ml foam pump for Rs. 90 with 120 applications.

Klenza hand sanitizers are available in select stores and malls acrossBangalore. You can also buy it online at stores like Flipkart, Amazon, FirstCry,PayTm etc.

ABOUT RESIL CHEMICALS PVT LTD:

Resil Chemicals Private Limited is a pioneer of silicone formulations for textilefinishing in India and one of Asia’s largest formulators of customizedsilicones for textile and non-textile applications. Since its inception in 1994,the company has diversified its product range to include specialty chemicalsfor textile and non-textile applications, emerging technology based productssuch as hand sanitizers, disinfectants and products for automobile detailing.Today Resil employs more than 300 people and has offices across Asia inIndia, Thailand, Myanmar, Bangladesh and Sri Lanka. The Company which wasfounded in Bangalore, India, has grown to meet the technical and scientificrequirements of the global market, helping customers to move forward.Resil’s vision is to be an organization that delivers optimum value andsatisfaction to all stakeholders and the community at large. The companyensures that the offered products & services are aimed at improving healthor user comfort and lifestyle aspirations of the society it serves withadequate environmental care.

Introducing a Safer Hand Sanitizerwith Lasting Protection!KLENZA – INDIA’S ONLY SILVER ENRICHED ALCOHOL FREE HANDSANITIZER WITH 3 HOUR GERM PROTECTION


Haydon Kerk MotionSolutions, a recognizedleader in linear and rotary

motion solutions, is pleased tointroduce the Catalyst Motion Groupas a supplier of integrated motionsystems.

Catalyst offers custom high-precision linear and rotary motionsystems from the very simple to thevery complex, and at any level ofintegration.

Catalyst understands the many facetsof motion system technology and isfocused on harnessing thatknowledge to develop next-levelapplication specific solutions. Withglobal resources and an expertise in

manufacturing and engineering thatis related specifically to linear androtary motion systems, Catalyst isuniquely positioned to provide full-service integrated motion systemdevelopment, design, test andmanufacture.

Navigating the world of motioncontrol technology can beintimidating, especially since thetechnology is continually evolving.Catalyst Motion Group can helpmake sense of the world of motioncontrol and make it accessiblethrough its own expert resourcesand strategic alignment within theindustry.

More information on Catalyst Motion

Haydon Kerk™ Motion Solutions IntroducesIts Latest Addition: Catalyst Motion Group

Group can be found at its website:www.catalystmotiongroup.com. Forhelp with a specific application, call1-203-725-3852 or [email protected] Motion Group, 1500Meriden Road, Waterbury, CT 06705.Phone: 203-725-3852. Fax: 203-756-8724

About Catalyst Motion Group

Catalyst Motion GroupTM is a brandof AMETEK® Precision MotionControl. It offers high-precision linearmotion systems at any level ofsophistication and integration,providing all necessary mechanical,electrical and software componentsand support. Its expertise includes

both single-axis and multiple-axissystems that use Haydon, Kerk,Pittman and Dunkermotorencomponents or are customdesigned to client’s specifications.

Catalyst brings the resources andsupport of a global corporation toits customers, who receiveindividual attention from the singlepoint contact of a small, focusedand strategically aligned group.

AMETEK Precision Motion Control isa division of AMETEK, Inc., a leadingglobal manufacturer of electronicinstruments and electromechanicaldevices with 2014 annual sales of$4.0 billion.


Kidney diseases have become a major public health problemwhich is a leading cause of morbidity and mortality in India andother low- and middle-income countries. Many people who

have kidney disease don't know it because the early signs can be verysubtle.

It can take many years to go from chronic kidney disease (CKD) tokidney failure. Most people with this disease live out their liveswithout ever reaching kidney failure. Depending on the underlyingcause], some types of kidney disease can be treated.

Often, though, chronic kidney disease has no cure. In general,treatment consists of measures to help control signs and symptoms,reduce complications, and slow progression of the disease.

If your kidneys can't keep up with waste and fluid clearance on theirown and you develop complete or near-complete kidney failure, youhave end-stage kidney disease. At that point, dialysis or a kidneytransplant is needed. Hemodialysis is the most common way to treatadvanced kidney failure.

“Hemodialysis is a treatment that removes wastes and extra fluid fromyour blood when your own kidneys have failed. Before hemodialysiscan be done, a connection must be made to the blood inside yourblood vessels.

Your hemodialysis access, or vascular access, is a way to reach yourblood for hemodialysis. The access allows your blood to travel

AV fistula incision for patientsundergoing Hemodialysis

through soft tubes to the dialysismachine where it is cleaned as itpasses through a special filter, calleda dialyzer.

An AV (artery-vein) fistula is the bestchoice for hemodialysis. It ispreferred because it usually lastslonger and has fewer problems likeclotting and infections.

A fistula should be placed severalmonths before you need to startdialysis. This allows the fistulaenough time to be ready for whenyou need treatment. A fistula (alsocalled an arteriovenous fistula or A-Vfistula) is made by joining an arteryand a vein under the skin in yourarm.

When the artery and vein are joined,the pressure inside the veinincreases, making the walls of thevein stronger. The stronger vein canthen receive the needles used forhemodialysis. . Your wrist or elbowis the preferred location for your

fistula. A fistula will usually last formany years.

A fistula usually takes one to fourmonths to “mature” or enlargebefore it can be used.” says Dr.Rakesh Mahajan, Head VascularSurgery, Apollo Hospitals, Delhi.There are two different types ofaccess that can be placed forhemodialysis apart from AV Fistula.They are called, A-V graft, and aCatheter.

Minor surgery is needed to createthe fistula. Connecting a vein to anearby artery, usually in your arm,makes it. This creates a large bloodvessel that has a fast flow of blood.Your wrist or elbow is the preferredlocation for your fistula.

It’s done under local anesthesia ondaycare basis. Infectious complica-tions of the AV fistulas are redness,swelling, soreness, feeling ofwarmth around your access site;fever, chills, and achy feeling.


Gove

rnm

ent o

f Ind

ia, Re

gistr

ar of

New

spap

ers o

f Ind

ia (R

NI)#:

DEL

ENG/

2009

/300

08

Date post:	24-Jul-2016
Category:	Documents
Upload:	worldwide-publications
View:	230 times
Download:	3 times

Medical Device ASIA, November-December 2015 issue

Documents